Physician-scientist and medical humanities
What ORCID Is and Why Persistent Identifiers Matter
An ORCID iD distinguishes a research contributor from similar names and connects that person to works and affiliations through traceable metadata.
Evidence and health education collection
Health & Evidence Library
Plain-language health education and evidence explainers spanning prevention, research literacy, chronic disease, and whole-person care.
18 topic areas
Scroll horizontally to inspect the full figure. A complete text version follows.
Read the figure in text
The figure presents four entry points. Urgent symptoms focuses on warning patterns and timing. Tests and results focuses on what a result can and cannot answer. Treatment decisions compares benefit, harm, burden, uncertainty, and priorities. Reading the evidence matches a question to a study design and checks bias, precision, and applicability.
Evidence and research methods
How Preprints Are Screened Before Posting
Preprint screening checks scope, ethics signals, privacy, duplication, and possible harm, but it does not certify the research through peer review.
Health policy, systems, and equity
How Europe Funds Deep Tech: Grant Plus Equity
The EIC Accelerator can combine a project grant with an equity or quasi-equity investment, but the two components follow different decisions.
Evidence and research methods
Research Embargoes and the Ingelfinger Rule
Journal embargoes coordinate reporting around publication; prior-publication rules decide whether earlier sharing affects manuscript eligibility.
Precision medicine and genetics
How a Genetic Variant Gets Classified
Laboratories combine population, clinical, family, functional, and computational evidence to classify germline sequence variants.
Health policy, systems, and equity
Early Health Technology Assessment Explained
Early HTA tests the potential value of a health innovation while its design, evidence plan, and investment choices can still change.
Physician-scientist and medical humanities
Why This Library Exists: An Evidence-Led, Human-Reviewed Project
Why this growing educational library exists, how its sources are selected, and how Jasaman Tojjar reviews every case analysis and evidence guide.
Women's, men's, and reproductive health
Urinary Incontinence in Women: Stress, Urge, and Pelvic Floor Therapy First
Stress incontinence leaks with a cough; urge incontinence follows sudden urgency. Pelvic floor and bladder training are first-line for both.
Children and adolescent health
The Childhood Immunization Schedule, Explained for Parents
What the childhood vaccine schedule covers from birth to 18, why babies get several shots at once, and how vaccine safety is monitored.
Prevention, nutrition, and travel health
Shingles and the Shingrix Vaccine: Who Should Get It
Who should get the Shingrix shingles vaccine, how well it works, and its side effects, based on current CDC and ACIP recommendations.
Brain, aging, and sleep health
Restless Legs Syndrome: Iron First and the Dopamine-Agonist Caution
Restless legs syndrome: why current guidance checks iron and ferritin first, favors gabapentinoids, and treats dopamine agonists with caution.
Women's, men's, and reproductive health
PMS and PMDD: Ordinary Premenstrual Symptoms Versus a Treatable Disorder
How to tell ordinary PMS from PMDD: the severity, timing, and functional impairment that mark a treatable disorder, plus what the evidence supports.
Skin, musculoskeletal, and eye health
Pink Eye and the Acute Red Eye: Common Causes Versus Dangerous Ones
How to tell viral, bacterial, and allergic pink eye apart, what antibiotic drops really do, and the red-eye warning signs that need urgent care.
Heart, lung, and acute care
Peripheral Artery Disease and the Ankle-Brachial Index
Recognize peripheral artery disease: what claudication feels like, why legs ache when walking, and how the ankle-brachial index confirms it.
Infection, immunity, and cancer
Outpatient Cellulitis: Purulent Versus Nonpurulent Skin Infection
How the purulent versus nonpurulent split sorts skin infections, why it guides antibiotic choice, and the red flags that mean urgent care.
Kidney, digestive, and blood health
Hyperkalemia: How High Potassium Is Recognized and Why It Matters
What causes high potassium, its symptoms, why kidney disease and ACE inhibitors raise it, and when hyperkalemia becomes a medical emergency.
Kidney, digestive, and blood health
Hemorrhoids and Common Anorectal Problems
Home care for hemorrhoids and anal fissures, how to tell them apart, and the rectal bleeding red flags that mean you should get checked.
Kidney, digestive, and blood health
Heartburn Relief That Actually Works: Reflux Self-Care and Its Limits
Evidence-based heartburn relief: which self-care steps and medicines work, how antacids, H2 blockers, and PPIs differ, and when to get checked.
Women's, men's, and reproductive health
Genital Herpes: Facts, Testing, and What Treatment Can Do
Plain facts about genital herpes: how HSV spreads, what type-specific testing can and cannot tell you, and what antiviral treatment achieves.
Kidney, digestive, and blood health
Gallstones: When They Need Treatment and When They Do Not
Most gallstones cause no symptoms and are left alone. Learn which ones need surgery, what a gallbladder attack feels like, and the red flags.
Kidney, digestive, and blood health
Food Intolerance or Food Allergy? How the Two Differ
A food allergy is an immune reaction that can be dangerous; an intolerance is non-immune. How to tell them apart and test wisely.
Children and adolescent health
Fever in Children: A Calm Triage Guide for Parents
How to read a child's fever calmly: age-based red flags, which comfort measures have evidence, and when a fever means it is time to get care.
Brain, aging, and sleep health
Everyday Headaches: Tension-Type, Migraine, and Cluster
Tension-type, migraine, and cluster headaches differ in pain, timing, and triggers. Learn how to tell them apart and which red flags need urgent care.
Brain, aging, and sleep health
Dizziness and Vertigo: BPPV and the Dix-Hallpike and Epley Maneuvers
Why the room spins when you lie down is often BPPV. How vertigo differs from lightheadedness, and how the Dix-Hallpike and Epley maneuvers work.
Brain, aging, and sleep health
Deprescribing in Older Adults: How a Structured Polypharmacy Review Works
How deprescribing and a structured polypharmacy review work in older adults, when to stop medicines safely, and how to spot drug-caused symptoms.
Kidney, digestive, and blood health
Chronic Constipation: A Stepwise, Evidence-Based Approach to Relief
How to relieve chronic constipation: start with fiber and fluids, step up to an osmotic then a stimulant laxative, and know the alarm signs that need care.
Mental and behavioral health
Bipolar Disorder: Recognition and When Primary Care Refers
How to recognize bipolar disorder, tell bipolar from unipolar depression, spot hypomania, and know when primary care refers to psychiatry.
Heart, lung, and acute care
Atrial Fibrillation: Rate Control, Rhythm Control, and Early Rhythm Control
How rate control, rhythm control, and early rhythm control differ in atrial fibrillation, what EAST-AFNET 4 changed, and how the choice is made.
Mental and behavioral health
Alcohol Use Disorder: The Evidence for Naltrexone and Acamprosate
Naltrexone and acamprosate are non-controlled medicines that help many people drink less or stop. Here is what the evidence shows.
Infection, immunity, and cancer
Acute Sinus Symptoms and the Antibiotic Question
Most sinus infections are viral and clear without antibiotics. Learn the viral vs bacterial clues, the 10-day rule, and what actually relieves symptoms.
Diabetes and metabolic health
Tirzepatide Versus Semaglutide for Weight Loss: Reading the Head-to-Head Evidence
SURMOUNT-5 head-to-head data on tirzepatide (Zepbound) versus semaglutide (Wegovy) for weight loss: how much each works, side effects, and choosing.
Infection, immunity, and cancer
Strep Throat or a Viral Sore Throat? Reading the Centor Score
Most sore throats are viral. The Centor (McIsaac) score estimates strep odds and when a throat swab or antibiotics are actually worth it.
Physician-scientist and medical humanities
Is This Medical Advice? Purpose, Scope, and Who Is Responsible
No. This site is an educational evidence library or diagnosis. Learn what it is, who is responsible, and when to see a clinician.
Diabetes and metabolic health
Continuous Glucose Monitors for People Without Diabetes: Does the Evidence Support Them?
Over-the-counter CGMs are marketed to healthy people, but the evidence for benefit is thin. Here is what glucose data does and does not tell you.
Heart, lung, and acute care
Cold, Flu, COVID, or RSV: How These Illnesses Are Told Apart
Flu, COVID, colds, and RSV overlap heavily. Compare symptoms, testing, and how long each stays contagious, plus when to test and seek care.
Heart, lung, and acute care
Acute Bronchitis and the Cough That Lingers
Acute bronchitis is almost always viral. The cough can last up to three weeks, and antibiotics rarely help. Here is the evidence and the red flags.
Evidence and research methods
Why Context Matters in Screening
A screening test's value depends on population risk, test thresholds, treatment benefit, follow-up capacity, harms, and the full care pathway.
Imaging and radiology
Why BI-RADS 4 Is Not a Breast Cancer Diagnosis
BI-RADS 4 means a breast imaging finding is suspicious enough for tissue sampling, not that imaging has diagnosed cancer.
Imaging and radiology
Whole-Body MRI Screening for Healthy People: What the Evidence Shows
Whole-body MRI avoids ionizing radiation, but incidental findings, false results, overdiagnosis, and missing outcome evidence limit screening use.
Digital health and AI
WHO's Six Principles for Artificial Intelligence in Health
WHO's six AI ethics principles become useful when translated into concrete design, procurement, deployment, monitoring, and redress controls.
Health policy, systems, and equity
Who Uses a Clinical Algorithm Has a Nondiscrimination Duty
Section 1557 makes covered health entities responsible for identifying and mitigating discrimination risk in patient care decision-support tools.
Heart, lung, and acute care
Who Should Be Tested for Alpha-1 Antitrypsin Deficiency?
Testing for alpha-1 antitrypsin deficiency belongs in routine COPD care and several lung, liver, skin, vascular, and family settings.
Evidence and research methods
When Not to Pool a Meta-Analysis
A pooled estimate can mislead when studies answer different questions, use incompatible outcomes, contain major bias, or vary in effect direction.
Digital health and AI
When More Health Data Is Not Better Evidence
Large health datasets shrink random error but can preserve bias, weak proxies, leakage, missingness, and drift with impressive precision.
Chronic disease in primary care
When a Joint Problem Needs Imaging, and Which Test Comes First
Joint imaging should answer a management question. Trauma, red flags, examination, and suspected tissue determine whether X-ray, ultrasound, or MRI fits.
Digital health and AI
When a Health Algorithm Should Say I Don't Know
Safe health AI needs a tested abstention pathway for unfamiliar, incomplete, conflicting, or uncertain cases, plus a reliable human fallback.
Digital health and AI
What WHO Guidance Says About Large Multimodal Models in Health
A practical reading of WHO's guidance on governing generative AI that can process text, images, audio, or video in health settings.
Diabetes and metabolic health
What Twin Studies Reveal About Diabetes, Genes, and Environment
Twin studies show strong genetic liability for diabetes while discordant identical twins prove that genes do not determine one person's outcome.
Infection, immunity, and cancer
What Tumor Mutational Burden Does and Does Not Tell You
Tumor mutational burden counts selected mutations per megabase. It can inform immunotherapy choices, but platform and tumor context matter.
Heart, lung, and acute care
What Troponin Measures, and Why a High Result Is Not a Diagnosis
Cardiac troponin detects heart-muscle injury. A heart attack diagnosis also requires a changing pattern and evidence of ischemia.
Digital health and AI
What Time in Range Means in Glucose Data
Time in range summarizes continuous glucose monitor readings within a defined interval. Learn the standard metrics, evidence, limits, and safe interpretation.
Skin, musculoskeletal, and eye health
What the WADA Prohibited List Is, and How to Use It Safely
The 2026 WADA Prohibited List classifies banned substances and methods, but safe medication decisions require more than a name search.
Heart, lung, and acute care
What the Vaping Lung Injury Outbreak Taught Us About Causation
The EVALI investigation linked vitamin E acetate in THC vaping products to lung injury through epidemiology, product tests, and lung-fluid analysis.
Physician-scientist and medical humanities
What the Tuskegee Study Changed About Research Oversight
The U.S. Public Health Service syphilis study used deception and withheld treatment. Its disclosure accelerated federal research protections.
Prevention, nutrition, and travel health
What the Trials Actually Show About Intensive Behavioral Weight Loss Programs
Intensive programs produce modest average weight loss, improve diabetes risk in selected groups, and require maintenance rather than a short course.
Evidence and research methods
What the STAR*D Reanalysis Debate Teaches About Trial Fidelity
The STAR*D debate shows how outcome definitions, analysis populations, missing data, and protocol fidelity can materially change a trial's headline.
Chronic disease in primary care
What the REVISE Trial Changed About Stress Ulcer Prophylaxis
REVISE found pantoprazole reduced clinically important upper gastrointestinal bleeding during invasive ventilation without changing 90-day mortality.
Chronic disease in primary care
What the History and Physical Examination Still Contribute to a Diagnosis
History and examination set pretest probability, identify urgency, and guide testing. Their value depends on technique, reliability, and the clinical question.
Heart, lung, and acute care
What the Fleischner Rules Say About an Incidental Lung Nodule
Fleischner guidance uses nodule size, solidity, number, and cancer risk to limit unnecessary follow-up while finding nodules that need closer evaluation.
Heart, lung, and acute care
What the FEV1/FVC Ratio Actually Measures on a Spirometry Report
FEV1/FVC describes how much of a forced breath leaves in the first second. It detects obstruction but does not name the cause or severity alone.
Chronic disease in primary care
What the Evidence Actually Shows for the Sepsis Hour-1 Bundle
Early sepsis care matters, especially in shock, but bundle components differ and the 2026 guideline stratifies antibiotic urgency by certainty.
Heart, lung, and acute care
What the DLCO Test Reveals About Gas Transfer
DLCO estimates how readily carbon monoxide moves from inhaled gas into blood. Learn what lowers or raises it, how technique matters, and why KCO differs.
Heart, lung, and acute care
What the Apnea Hypopnea Index Does and Does Not Tell You
The apnea hypopnea index counts breathing events per hour of sleep. It does not fully measure oxygen stress, symptoms, sleep disruption, or individual risk.
Prevention, nutrition, and travel health
What the 2024 Falls Prevention Update Changed, and Why Vitamin D Was Dropped
The 2024 USPSTF update kept exercise and selective multifactorial care while moving vitamin D into a separate prevention review.
Skin, musculoskeletal, and eye health
What SPF Really Measures, and Why 100 Is Not Twice as Good as 50
SPF is a standardized sunburn-protection ratio, not a timer or a complete measure of UVA protection. Learn how labeling, amount, and reapplication matter.
Evidence and research methods
What Real-World Data Sources Actually Look Like
A practical guide to claims, electronic records, registries, devices, and linked data, including what each source records and systematically misses.
Evidence and research methods
What Procalcitonin and CRP Can and Cannot Decide About Antibiotics
How procalcitonin and C-reactive protein can support antibiotic stewardship without replacing diagnosis, severity assessment, cultures, or reassessment.
Health policy, systems, and equity
What Orphan Drug and Rare Disease Pathways Do
Orphan designation creates development incentives for rare-disease products. It is not approval, proof of effectiveness, or automatic exclusivity.
Diabetes and metabolic health
What Mendelian Randomization Can and Cannot Show
Mendelian randomization uses genetic variants as instruments for causal questions. Its conclusions depend on relevance, independence, exclusion, and design.
Evidence and research methods
What Makes Science Communication Trustworthy
Trustworthy science communication makes evidence traceable, calibrates certainty, quantifies effects, discloses interests, and corrects errors visibly.
Digital health and AI
What Makes a Health AI Tool Explainable to a Patient
A patient-facing AI explanation should clarify purpose, inputs, basis, uncertainty, options, accountability, and recourse, not merely display model internals.
Evidence and research methods
What Makes a Biomarker Clinically Useful
A useful biomarker must be measurable, valid for a defined purpose, and capable of improving a decision. Association alone is not enough.
Heart, lung, and acute care
What Lipoprotein(a) Measures and Why It Matters
Lipoprotein(a) is an inherited apoB particle linked to atherosclerotic disease and aortic stenosis. Learn testing, units, interpretation, and limits.
Evidence and research methods
What Large Replication Projects Actually Found
Major replication projects found smaller effects, mixed repeatability, and practical barriers. Their results require more nuance than a single failure rate.
Medicines and drug development
What Is a Peptide? Structure, Function, and Medicines
Peptides are short amino-acid chains with diverse biological roles. Learn how peptide medicines work, why delivery is difficult, and how to assess claims.
Diabetes and metabolic health
What Informed Consent Really Means
Informed consent is an ongoing, voluntary communication process in clinical research, not a signature. Learn its elements, safeguards, and limits.
Health policy, systems, and equity
What ICH E6(R3) Changed in Good Clinical Practice
ICH E6(R3) modernized GCP through quality by design, proportionality, clearer accountability, data governance, and support for varied trial designs.
Diabetes and metabolic health
What Heritability Really Means
Heritability describes variation in a population under particular conditions; it does not measure genetic destiny, immutability, or an individual's risk.
Health policy, systems, and equity
What Health Technology Assessment Does
Health technology assessment combines clinical, economic, ethical, social, and organizational evidence to inform transparent health-system decisions.
Digital health and AI
What Health Economics Asks
Health economics examines scarcity, opportunity cost, incentives, equity, and how costs and outcomes change when health systems choose among alternatives.
Chronic disease in primary care
What Good Primary Care Does
Good primary care provides first contact, continuity, comprehensive care, coordination, prevention, and decisions grounded in a person's goals and context.
Health policy, systems, and equity
What Good Clinical Practice Requires
Good Clinical Practice protects participants and result reliability through ethics, consent, quality by design, oversight, data integrity, and transparency.
Evidence and research methods
What Good Clinical Evidence Looks Like
Good clinical evidence fits a precise question and withstands scrutiny for bias, precision, relevance, transparency, replication, and applicability.
Diabetes and metabolic health
What Genome-Wide Association Studies Show
GWAS identify statistical links between genomic regions and traits. Learn how they work, why association is not causation, and what scores inherit.
Skin, musculoskeletal, and eye health
What FRAX Does and Does Not Tell You
FRAX estimates 10-year hip and major osteoporotic fracture probability. Learn what goes into the estimate, what it omits, and how thresholds differ.
Digital health and AI
What Foundation Models Mean for Medicine
Foundation models can be adapted across medical tasks, but broad pretraining does not establish clinical validity, safety, regulation, or patient benefit.
Evidence and research methods
What External Validity Means
External validity asks whether a study's results apply to a defined target beyond the study, across people, settings, treatments, outcomes, and time.
Heart, lung, and acute care
What Ejection Fraction Measures
Ejection fraction is the percentage of a ventricle's filled volume pumped out with each beat. Learn what it measures, how methods differ, and what it misses.
Digital health and AI
What Decision-Curve Analysis Adds
Decision-curve analysis tests whether using a model could improve decisions across plausible thresholds while making assumptions and limits visible.
Prevention, nutrition, and travel health
What Decision Aids Do and What They Cannot Do
Patient decision aids improve knowledge and clarify values, but cannot choose for someone, guarantee outcomes, or replace clinical conversation.
Evidence and research methods
What ctDNA Minimal Residual Disease Can and Cannot Do
Learn how ctDNA molecular residual disease testing estimates recurrence risk, why a negative result cannot prove cure, and when treatment utility needs trials.
Heart, lung, and acute care
What BNP and NT-proBNP Measure
Learn what BNP and NT-proBNP reflect, how they help evaluate heart failure, and why age, kidney function, obesity, rhythm, medicines, and setting matter.
Diabetes and metabolic health
What Biosimilar Insulins Must Prove
Learn how FDA evaluates biosimilar insulin through analytical similarity, potency, PK and PD studies, immunogenicity, manufacturing quality, and labeling.
Infection, immunity, and cancer
What Antibiotic Susceptible and Resistant Mean: MIC Explained
Learn how laboratories measure MIC, apply breakpoints, and report susceptible, intermediate, or resistant results, plus the limits of an antibiogram.
Kidney, digestive, and blood health
What ANNEXA-I Shows About DOAC Reversal Agents
ANNEXA-I found better hematoma control with andexanet than usual care but more thrombosis. Learn what the trial did, what it did not prove, and the US update.
Imaging and radiology
What an FDG PET Scan Measures and SUV Pitfalls
Learn what FDG PET/CT shows, how standardized uptake values are calculated, and why inflammation, glucose, timing, lesion size, and scanner methods matter.
Health policy, systems, and equity
What an EU Joint Clinical Assessment Is
An EU joint clinical assessment analyzes relative clinical effects for national HTA. It does not decide price, reimbursement, or overall added value.
Kidney, digestive, and blood health
What Albuminuria Means: Reading a uACR Result
A urine albumin-to-creatinine ratio can reveal kidney damage before eGFR falls. Learn the A1, A2, and A3 categories and why repeat testing matters.
Infection, immunity, and cancer
What a Vaccine Correlate of Protection Is
A vaccine correlate of protection links an immune marker with reduced risk. Learn the evidence needed, how correlates speed decisions, and their limits.
Infection, immunity, and cancer
What a Tumor-Agnostic Approval Means
A tumor-agnostic approval targets a molecular feature across specified cancers, not every tumor. Learn how basket trials, testing, labels, and uncertainty fit.
Skin, musculoskeletal, and eye health
What 'Clinically Proven' Really Means
Clinically proven is a claim, not a study design. Learn how to check the exact product, outcome, comparator, trial quality, effect size, harms, and regulation.
Prevention, nutrition, and travel health
Weight and Metabolic Health: What the Measures Mean
Weight is one health measure, not a complete diagnosis. Learn how BMI, waist size, blood pressure, glucose, lipids, function, and context fit together.
Diabetes and metabolic health
Vitamin D Screening: What the Evidence Supports
Routine vitamin D blood testing in asymptomatic adults has unproven benefit. Learn what 25-hydroxyvitamin D measures and when targeted testing differs.
Prevention, nutrition, and travel health
Vitamin D and Calcium for Fractures: The Evidence
Routine vitamin D or calcium supplements prevent few or no fractures in most community adults. Learn what trials show and which clinical groups are different.
Prevention, nutrition, and travel health
Visceral Fat and Metabolic Risk: What We Can Measure
Visceral fat surrounds abdominal organs and tracks cardiometabolic risk. Learn what waist size, imaging, BMI, and laboratory markers can and cannot show.
Skin, musculoskeletal, and eye health
Vertebroplasty: What Sham-Controlled Trials Reveal
Sham-controlled vertebroplasty trials show why procedure studies need credible placebos, careful fracture timing, and outcomes beyond pain improvement alone.
Evidence and research methods
Verification Bias in Diagnostic Accuracy Studies
Verification bias occurs when disease confirmation depends on the test result or patient features. Learn how it distorts sensitivity and specificity.
Women's, men's, and reproductive health
Varicocele Repair and Semen Parameters: The Evidence
Learn when AUA and ASRM guidance considers varicocele repair, what semen changes studies report, and why pregnancy and live birth matter beyond a lab result.
Infection, immunity, and cancer
Vaccine Efficacy vs Effectiveness: How Each Is Measured
Vaccine efficacy measures relative risk reduction in a trial; effectiveness estimates performance in practice. Learn the designs, endpoints, biases, and limits.
Skin, musculoskeletal, and eye health
USPSTF Sun-Protection Counseling: Reading the Evidence
Learn why the USPSTF recommends sun-protection counseling through age 24 for fair skin types and selectively offers it later in adulthood.
Evidence and research methods
USPSTF Statin Guidance for Primary Prevention
Learn how the USPSTF combines age, risk factors, and 10-year cardiovascular risk when recommending statins to prevent a first heart attack or stroke.
Infection, immunity, and cancer
Undetectable Equals Untransmittable: The Evidence
U=U means sustained HIV viral suppression prevents sexual transmission. Learn what the studies showed, what undetectable means, and the message's boundaries.
Prevention, nutrition, and travel health
Understanding Your Lipid Panel in 2026
Learn what LDL-C, HDL-C, triglycerides, non-HDL-C, apoB, and lipoprotein(a) measure, and why a lipid panel must be read with overall risk.
Evidence and research methods
Understanding Standardized Mean Differences
How standardized mean differences combine outcomes measured on different scales, and why scale direction, variability, bias, and context matter.
Evidence and research methods
Understanding Selection Bias in Health Research
Selection bias explained through recruitment, follow-up, referral, missing data, conditioning, and the checks that make study results more credible.
Chronic disease in primary care
Understanding Rotator Cuff Problems
Rotator cuff pain and tears explained: symptoms, examination, imaging, rehabilitation, injections, surgery, and signs that need prompt assessment.
Digital health and AI
Understanding Overfitting in Clinical Models
Why clinical models overfit, how optimism appears, and which validation practices reveal whether performance will travel beyond development data.
Evidence and research methods
Understanding Competing Risks
Competing events change the meaning of a survival curve. Cumulative incidence, cause-specific hazards, and Fine-Gray models answer different questions.
Chronic disease in primary care
Understanding Carpal Tunnel Syndrome
Carpal tunnel syndrome compresses the median nerve at the wrist. Symptom pattern, severity, and diagnostic uncertainty guide testing and treatment.
Prevention, nutrition, and travel health
Understanding Cardiovascular Risk Scores
Cardiovascular risk scores estimate group-based probability over a stated horizon; the equation, outcome, population, and clinical context determine meaning.
Diabetes and metabolic health
Understanding Basal and Bolus Insulin
Basal insulin covers background needs between meals, while bolus insulin addresses food and high glucose; safe use depends on patterns and timing.
Kidney, digestive, and blood health
Uncomplicated Diverticulitis and the Antibiotic Question
Trials support selective care without antibiotics for some immunocompetent adults with mild uncomplicated diverticulitis, not for every patient.
Evidence and research methods
Umbrella Reviews and Overviews of Reviews
Umbrella reviews synthesize reviews, but overlap, variable methods, stale searches, and inherited bias can overstate certainty.
Imaging and radiology
Ultrasound First for Kidney Stones: What the STONE Trial Showed
The STONE trial found that starting with ultrasound lowered cumulative radiation while serious outcomes were similar to a CT-first strategy.
Physician-scientist and medical humanities
Type 2 Diabetes Subtypes: Useful Biology or Premature Labels?
Cluster studies reveal heterogeneity within adult-onset diabetes, but proposed subtypes are not yet routine diagnostic categories or treatment rules.
Diabetes and metabolic health
Type 2 Diabetes Remission: What the Term Means and What It Does Not
Type 2 diabetes remission has a specific definition. Learn how it is measured, how it may occur, why relapse happens, and what follow-up remains necessary.
Chronic disease in primary care
Trigger Finger: Why a Digit Catches and How Care Works
Learn why trigger finger catches, how it is diagnosed, and how observation, splinting, corticosteroid injection, and pulley release compare.
Evidence and research methods
Trial Registration and Results Reporting
Trial registration records the planned question, while structured results reporting reveals completed studies and outcome changes.
Chronic disease in primary care
Treatment Burden and Minimally Disruptive Medicine
Minimally disruptive medicine fits effective care to capacity by reducing avoidable appointments, monitoring, costs, and coordination work.
Skin, musculoskeletal, and eye health
Treat-to-Target Urate Lowering: What the Evidence Supports
Gout guidelines support titration using serial serum urate, usually toward less than 6 mg/dL, while risks and disease severity shape care.
Diabetes and metabolic health
Treat-to-Target Design in Insulin Trials
Treat-to-target insulin trials seek the same glucose goal, making hypoglycemia, dose, weight, safety, and usability central comparisons.
Digital health and AI
Transportability of Clinical Prediction Models
Prediction models can fail elsewhere when populations, measurements, workflows, treatments, and outcome definitions change.
Skin, musculoskeletal, and eye health
Training Adaptation: Stress, Recovery, and Specificity
Training creates a signal, while recovery permits adaptation. Learn how specificity, progression, fatigue, muscle, tendon, and aerobic systems interact.
Skin, musculoskeletal, and eye health
Topical Retinoids for Photoaging: What the Trials Show
Trials support modest improvement in several signs of facial photodamage with topical tretinoin, alongside common irritation and clear limits.
Brain, aging, and sleep health
Time Is Brain: What the Stroke Treatment Evidence Actually Shows
Stroke benefit generally falls with treatment delay, but eligibility depends on stroke type, imaging, severity, timing, and individual risk.
Imaging and radiology
TI-RADS and Thyroid Cancer Overdiagnosis
TI-RADS uses ultrasound features and size thresholds to find consequential thyroid cancers while limiting biopsies of small indolent nodules.
Diabetes and metabolic health
Thyroid Nodules: TI-RADS and Bethesda Answer Different Questions
TI-RADS scores ultrasound features and biopsy thresholds. Bethesda classifies sampled cells. Learn how the two systems guide one thyroid nodule pathway.
Health policy, systems, and equity
Three Functions of Health Financing
Revenue raising, pooling, and purchasing determine who pays, how financial risk is shared, and which services providers deliver.
Women's, men's, and reproductive health
The Women's Health Research Gap Is More Than Enrollment
Women's enrollment has improved, but evidence gaps persist in preclinical design, pregnancy, menopause, condition-specific funding, and subgroup analysis.
Women's, men's, and reproductive health
The WHI Timing Hypothesis, More Than Twenty Years Later
What WHI follow-up, ELITE, and current guidance do and do not show about when menopausal hormone therapy is started.
Women's, men's, and reproductive health
The TRAVERSE Trial: What It Showed and What It Did Not
TRAVERSE found cardiovascular noninferiority for testosterone gel in selected men with confirmed hypogonadism and cardiovascular risk.
Physician-scientist and medical humanities
The Translation Gap Is Not One Gap
Moving from discovery to routine benefit requires linked evidence about mechanisms, trials, implementation, access, and population outcomes.
Diabetes and metabolic health
The Thrifty Gene Hypothesis: An Unfinished Idea
The thrifty gene hypothesis links past food scarcity with modern metabolic disease, but its selection story and genetic predictions remain unsettled.
Evidence and research methods
The Table 2 Fallacy: One Model, Many Wrong Questions
A multivariable regression table may display many coefficients, but each causal question can require a different adjustment set and interpretation.
Evidence and research methods
The Placebo Effect, Without the Myths
Placebo responses mix context, natural change, and measurement. Learn what placebo effects can change, what they cannot prove, and why controls matter.
Diabetes and metabolic health
The Pancreatic Islet: A Glucose-Control Network
Pancreatic islets coordinate insulin, glucagon, somatostatin, blood flow, nerves, and nutrient signals to stabilize metabolism between meals.
Physician-scientist and medical humanities
The Nuremberg Code and the Limits of Consent
The 1947 Nuremberg Code made voluntary consent foundational to research ethics, while later frameworks built protections beyond a signed form.
Evidence and research methods
The Nocebo Effect: Symptoms Are Real, Causes Are Mixed
Nocebo effects can amplify symptoms through expectation and learning. Good communication reduces avoidable harm without hiding genuine treatment risks.
Chronic disease in primary care
Tendon Injuries and Healing: A Practical Evidence Guide
Learn how acute tendon tears and tendinopathy differ, why recovery takes time, how loading guides rehabilitation, and which warning signs need prompt care.
Evidence and research methods
Real-World Data After Approval: What It Can Add
After approval, real-world data can detect rare harms and study use in broader populations, but design and data quality determine credibility.
Digital health and AI
Prediction Versus Explanation in Clinical Models
Prediction estimates what is likely to happen; explanation asks why. Clinical models need a question, design, and validation matched to that purpose.
Diabetes and metabolic health
Pharmacokinetics and Pharmacodynamics Explained
Pharmacokinetics tracks drug concentration over time; pharmacodynamics links concentration to effects. Learn ADME, half-life, clearance, response, and dosing.
Evidence and research methods
Noninferiority Trials: How the Margin Determines the Claim
Learn how noninferiority margins, assay sensitivity, confidence intervals, missing data, and analysis populations determine whether a trial is credible.
Evidence and research methods
Medical Registries: What They Record and What They Miss
Disease, product, quality, and trial registries serve different purposes. Their credibility depends on coverage, definitions, and follow-up.
Evidence and research methods
Lead-Time Bias: Why Earlier Diagnosis Can Look Like Longer Survival
Earlier diagnosis automatically lengthens measured survival from diagnosis. Learn how mortality trials separate true screening benefit from lead-time bias.
Brain, aging, and sleep health
Large-Core Stroke Thrombectomy: What Changed
Trials from 2022 onward showed that selected large-core strokes can benefit from thrombectomy, informing expanded 2026 stroke guidance.
Skin, musculoskeletal, and eye health
Knee Steroid Injections: What the Triamcinolone-versus-Saline Trial Found on Cartilage and Pain
A two-year trial of triamcinolone every three months found greater cartilage loss and no sustained pain advantage over saline, with limits on interpretation.
Diabetes and metabolic health
Insulin Resistance in Plain Terms
Insulin resistance means tissues respond less effectively to insulin. Learn how the body compensates, what tests can show, and why context matters.
Evidence and research methods
Instrumental Variables: The Assumptions Behind a Natural Experiment
Instrumental-variable studies can address unmeasured confounding only under demanding assumptions. Learn relevance, independence, exclusion, and LATE.
Evidence and research methods
Incidental Findings: How Unexpected Results Should Be Interpreted
Unexpected findings on scans, tests, and sequencing can trigger useful care or harmful cascades. Learn how context and follow-up guidance shape decisions.
Evidence and research methods
Immortal Time Bias: How Misassigned Follow-Up Creates False Benefit
Immortal time bias can make treatment look protective when pre-treatment survival is credited to treatment. Learn how to detect and prevent it.
Evidence and research methods
Hazard Ratios: What They Measure and Why Absolute Risk Still Matters
A hazard ratio compares instantaneous event rates, not simple probabilities. Learn proportional-hazards assumptions, censoring, and better companion measures.
Diabetes and metabolic health
GLP-1-Based Therapies: Benefits, Limits, Safety, and Practical Use
Understand GLP-1 receptor agonists and dual GIP/GLP-1 therapy, including uses, outcomes, side effects, dose escalation, and safety.
Health policy, systems, and equity
GDPR, HIPAA, and Consumer Health Data: A Practical Privacy Map
A current, practical comparison of GDPR, HIPAA, the FTC Health Breach Notification Rule, and state consumer-health privacy laws.
Health policy, systems, and equity
External Reference Pricing: A Practical Guide
External reference pricing benchmarks a medicine against prices in other countries. Its result depends on the basket, price data, formula, and review rules.
Chronic disease in primary care
eGFR and Kidney Numbers: How to Read Creatinine, Filtration, and Trends
Understand eGFR, creatinine, cystatin C, albuminuria, CKD stages, race-free equations, and why one kidney number rarely tells the whole story.
Evidence and research methods
Diagnostic Accuracy Studies: How to Read Sensitivity, Specificity, and Bias
Learn how patient selection, reference standards, thresholds, verification, and prevalence determine whether diagnostic accuracy results will travel.
Diabetes and metabolic health
Diabetic Ketoacidosis: Warning Signs, Causes, and Emergency Treatment
Learn why diabetic ketoacidosis develops, how euglycemic DKA can occur, which warning signs matter, and why hospital treatment is urgent.
Diabetes and metabolic health
Diabetes Medication Classes: How the Main Options Differ
Compare insulin, metformin, SGLT2 inhibitors, GLP-1-based therapy, sulfonylureas, DPP-4 inhibitors, and other diabetes medicines.
Diabetes and metabolic health
Diabetes Burnout: Recognizing When Self-Management Becomes Too Much
Diabetes burnout and distress can make daily care feel impossible. Learn how to recognize overload, reduce burden, and find appropriate support.
Evidence and research methods
Contrast in Medical Imaging: What It Adds and How Risk Is Assessed
A practical guide to iodinated, gadolinium-based, ultrasound, and gastrointestinal contrast, including kidney and reaction risk.
Evidence and research methods
Confounding by Indication: Why Treated Groups Start Out Different
Confounding by indication can make helpful treatments look harmful, or ineffective treatments look useful, in observational medical research.
Mental and behavioral health
Antidepressants Can Start Working Before Week Four
Antidepressant effects can begin in the first weeks, while full response takes longer. Learn what early change means and when treatment needs review.
Mental and behavioral health
Zuranolone for Postpartum Depression: How to Read the FDA Approval
What the narrow FDA approval establishes about a 14-day oral treatment, and what its trials, label, and safety limits do not establish.
Chronic disease in primary care
Wrist Fractures and Recovery: From Injury to Function
How distal radius fractures are assessed, aligned, protected, and rehabilitated, including urgent warning signs and bone-health follow-up.
Health policy, systems, and equity
Why Usability Engineering Is a Medical Device Safety Control
How human factors work identifies critical tasks, improves interfaces, validates realistic use, and links use-related risk to FDA submissions.
Physician-scientist and medical humanities
Why the Words of a Diagnosis Matter
Diagnostic language can transmit evidence, uncertainty, respect, or bias. Better wording is accurate, contextual, preference-aware, and useful for care.
Diabetes and metabolic health
Why the USPSTF Diabetes Screening Age Moved to 35
What the U.S. screening recommendation at age 35 actually covers, why the threshold changed, and how abnormal results are confirmed.
Mental and behavioral health
Why Suicide-Risk Scores Miss the Individual
Why rare outcomes, changing circumstances, false positives, and false negatives prevent risk categories from deciding one person's care.
Heart, lung, and acute care
Why Sleep Apnea Screening Received an I Statement
Why the USPSTF found insufficient evidence for screening adults without recognized symptoms, despite available questionnaires and treatment.
Prevention, nutrition, and travel health
Why Sleep and Stress Can Change Blood Sugar
How sleep loss, circadian disruption, acute stress, illness, behavior, and diabetes burden can influence glucose without a simple one-way cause.
Prevention, nutrition, and travel health
Why Single-Disease Guidelines Struggle With Multimorbidity
How guideline stacking creates interactions and treatment burden, and how NICE NG56 reframes care around goals, benefit, harm, and coordination.
Infection, immunity, and cancer
Why Shorter Antibiotic Courses Are Often Enough
Trials support shorter antibiotic courses for selected infections, but the right duration depends on diagnosis, source control, response, and host risk.
Evidence and research methods
Why Screening Selects Slower Cancers and Inflates Survival Statistics
Length-time bias makes screen-detected cancers look less lethal because screening preferentially finds tumors with longer detectable phases.
Evidence and research methods
Why Retractions Are Rising and What They Mean
Why raw retraction counts are increasing, how paper mills and better detection contribute, and which metrics reveal whether correction works.
Evidence and research methods
Why Retracted Papers Keep Getting Cited
Why retraction notices fail to reach every PDF, reference list, review, guideline, and database, and how to stop unreliable evidence spreading.
Evidence and research methods
Why Research Use Only Is a Red Flag
What Research Use Only means for laboratory products, why it cannot support patient claims, and which evidence a clinical test needs.
Physician-scientist and medical humanities
Why Replication Studies Are Hard
Why repeating a study requires more than copying a methods section and how stronger replication designs clarify what a result means.
Heart, lung, and acute care
Why Reliever-Only Asthma Treatment Was Abandoned
Why treating asthma with a short-acting bronchodilator alone no longer meets current GINA safety standards and what replaced it.
Evidence and research methods
Why Pulse Oximeters Miss Low Oxygen in Darker Skin
How pulse oximeters estimate oxygen, why darker pigmentation can bias readings upward, and how safer interpretation reduces missed hypoxemia.
Physician-scientist and medical humanities
Why Public Trust in Science Is Earned
Why trustworthy methods, institutions, communication, accountability, and public participation matter more than demands to trust science.
Evidence and research methods
Why Psychotherapy Trials Are Hard to Blind
How awareness of treatment assignment affects psychotherapy trials and which design choices can preserve credible comparisons.
Physician-scientist and medical humanities
Why Promising Discoveries Do Not Reach Patients
A discovery must survive validation, engineering, funding, regulation, clinical testing, manufacturing, and implementation before it can improve care.
Medicines and drug development
Why Preclinical Breakthroughs Often Do Not Translate
How study design, biological relevance, reporting, replication, and incentives determine whether preclinical findings survive translation.
Prevention, nutrition, and travel health
Why Pneumococcal Vaccination Now Starts at Fifty
Why CDC lowered routine adult pneumococcal vaccination from age 65 to 50 and how the current vaccine pathways fit together.
Health policy, systems, and equity
Why Pilots Do Not Scale
Why a successful pilot is evidence of feasibility, not proof that an intervention will retain its effect, cost, or equity at scale.
Medicines and drug development
Why Peptide Purity and Immunogenicity Matter
Why a peptide purity percentage cannot establish identity, consistency, sterility, potency, stability, or immune safety.
Evidence and research methods
Why Overall Survival Is the Gold Standard in Cancer Trials
Why overall survival is uniquely persuasive in oncology, where it can mislead, and how to read earlier endpoints alongside it.
Evidence and research methods
Why Obesity Drug Trials Differ From Diabetes Drug Trials
How indication, population, endpoints, duration, background care, safety questions, and estimands differ between obesity and diabetes programs.
Evidence and research methods
Why More Medical Testing Is Not Automatically Safer
How low pretest probability, false positives, incidental findings, overdiagnosis, and follow-up harms can make an untargeted test panel unsafe.
Heart, lung, and acute care
Why Lung Function Reference Equations Are Removing Race
Why laboratories are adopting race-neutral lung function equations, what changes on a spirometry report, and why clinical context still matters.
Prevention, nutrition, and travel health
Why Lifestyle Counseling Receives Different USPSTF Grades
Why related diet and physical-activity counseling earns a B grade with cardiovascular risk factors and a C grade without them.
Prevention, nutrition, and travel health
Why HIV Screening Is Recommended Once for Almost Every Adult
Why routine HIV screening uses broad age ranges, when repeat testing is needed, and how the antigen-antibody and confirmatory sequence works.
Prevention, nutrition, and travel health
Why Hepatitis C Screening Became a One-Time Test for Nearly All Adults
Why U.S. guidance expanded beyond the baby-boomer birth cohort, how antibody and RNA testing differ, and who needs repeat testing.
Evidence and research methods
Why Global Phase 3 Programs Outgrow One Power Calculation
Why a global confirmatory program may need more participants than the primary efficacy calculation, from safety and regions to subgroups and missing data.
Kidney, digestive, and blood health
Why Ferritin Thresholds for Iron Deficiency Differ
Why WHO, gastroenterology, kidney, and heart-failure guidance use different ferritin cutoffs, and why context and transferrin saturation matter.
Evidence and research methods
Why FDA Did Not Approve MDMA-Assisted Therapy for PTSD
What FDA's 2024 complete response said about efficacy, safety reporting, functional unblinding, durability, and the path for new evidence.
Women's, men's, and reproductive health
Why Endometriosis Can Take Years to Diagnose
Why endometriosis symptoms are missed, what normal imaging can and cannot rule out, and how 2026 guidance supports earlier clinical diagnosis.
Digital health and AI
Why Digital Health Tools Survive Routine Care
Durable digital health depends on clinical need, evidence, workflow fit, operations, governance, adaptation, and continued measurement.
Evidence and research methods
Why Diabetes Drugs Began Running Cardiovascular Outcomes Trials
How a 2008 FDA safety policy created the modern diabetes CVOT, what those trials test, what they discovered, and how U.S. policy later changed.
Physician-scientist and medical humanities
Why Debunking Can Leave Misinformation Behind
Why corrected claims can still shape memory and reasoning, and how fact-first corrections with a coherent alternative explanation can work better.
Evidence and research methods
Why Cognitive Bias Can Contribute to Diagnostic Error
Bias labels describe recurring reasoning patterns, but diagnostic error also reflects knowledge, data, workload, teamwork, and system design.
Evidence and research methods
Why an AI Tool Cannot Be an Author, and What Researchers Must Disclose
Current medical-publishing rules keep authorship human, require accountable verification, and call for transparent disclosure of AI assistance.
Evidence and research methods
Why Adult Suicide-Risk Screening Received an I Statement
What the USPSTF found insufficient about universal adult suicide-risk screening, and why that does not limit assessment when concern exists.
Prevention, nutrition, and travel health
Why Adult RSV Vaccine Advice Changed From Choice to Age and Risk
How adult RSV recommendations changed from broad shared decisions to clearer age- and risk-based rules, including the 2025 age expansion.
Diabetes and metabolic health
Why Adipose Tissue Is an Organ, Not Passive Storage
How adipose tissue stores and releases fuel, sends hormonal signals, supports immunity and temperature control, and changes with location.
Infection, immunity, and cancer
Why a Test's Positive Predictive Value Depends on Prevalence
A positive test can mean very different things in low-risk and high-risk groups. Learn how prevalence, pretest probability, and false positives shape PPV.
Health policy, systems, and equity
Why a Medical Device Clinical Investigation Is Not a Drug Trial Template
How device studies adapt good clinical practice to intended use, users, procedures, configurations, deficiencies, comparators, and design changes.
Evidence and research methods
Who Sees Interim Trial Results, and When Should a Trial Stop?
Data monitoring committees review interim benefit, harm, and futility using prespecified rules while protecting trial integrity.
Evidence and research methods
Who Counts as an Author? ICMJE and CRediT
ICMJE defines who qualifies for authorship; CRediT records contributor roles. Learn how accountability, AI use, groups, and acknowledgments fit.
Evidence and research methods
When Real-World Evidence Helps and When It Misleads
Real-world evidence can describe care, compare outcomes, and detect harms, but confounding, selection, missing data, and timing can mislead.
Evidence and research methods
When One Study Appears in Several Papers
How duplicate publication, fragmented reporting, and legitimate secondary publication affect readers and evidence synthesis.
Health policy, systems, and equity
When Equivalent Device Evidence Can Support an EU MDR Clinical Evaluation
A practical EU MDR guide to technical, biological, and clinical equivalence, data access, evidence gaps, and notified-body review.
Chronic disease in primary care
When Diagnostic Confidence Outruns Diagnostic Accuracy
Calibration asks whether diagnostic confidence matches accuracy. Evidence shows why difficult cases can feel more certain than they should.
Medicines and drug development
When Adult Drug Evidence Can Support Pediatric Development
How ICH E11A uses disease, pharmacology, response, dosing, formulation, and safety evidence to plan pediatric extrapolation.
Evidence and research methods
When a Single Hazard Ratio Hides a Time-Varying Effect
Proportional hazards is an assumption about a stable rate ratio over time. Curves, residuals, and time-based alternatives reveal when it fails.
Chronic disease in primary care
What Trials of General Health Checks Actually Show
Broad health checks have not reduced mortality in randomized trials, but that finding does not erase targeted prevention or ongoing care.
Evidence and research methods
What statcheck and GRIM Can Reveal From a Paper's Reported Numbers
Automated consistency checks can flag impossible means and mismatched p values, but every flag needs context and human review.
Health policy, systems, and equity
What Regulatory Meetings Do Across Drug Development
FDA drug-development meetings reduce uncertainty through precise questions, complete evidence packages, and controlled follow-through.
Diabetes and metabolic health
What Pharmacovigilance Does After a Medicine Is Approved
How safety reports become signals, how active surveillance tests them, and why one report cannot establish that a medicine caused an event.
Physician-scientist and medical humanities
What Medical Humanities Add to Clinical Practice
How ethics, history, narrative, language, and the arts sharpen observation, judgment, communication, and reflection without replacing science.
Evidence and research methods
What Blinded Outcome Review Adds to an Open-Label Trial
PROBE trials keep treatment open but blind endpoint assessment. This limits some judgment bias without repairing every consequence of open treatment.
Skin, musculoskeletal, and eye health
What an Eye Exam Can Reveal About Health, and What It Cannot Diagnose
How retinal, optic-nerve, vascular, and inflammatory findings can prompt broader health evaluation without replacing confirmatory testing.
Digital health and AI
What an Explanation in Medical AI Must Prove
Medical AI explanations need a defined audience, tested fidelity, stability, limits, and evidence that they support appropriate human decisions.
Evidence and research methods
What a Subgroup Analysis Shows
A subgroup analysis tests whether effects differ across groups. Credibility depends on interaction tests, planning, precision, and replication.
Skin, musculoskeletal, and eye health
What a Skin Biopsy Actually Decides: Breslow Depth and Melanoma Staging
A melanoma biopsy establishes diagnosis and primary-tumor features such as Breslow thickness and ulceration, but nodes and distant spread complete staging.
Health policy, systems, and equity
What a Regulatory Submission Contains
A medicine regulatory submission connects administrative, quality, nonclinical, clinical, labeling, and electronic evidence into a reviewable lifecycle.
Chronic disease in primary care
What a Primary Care Annual Review Covers
A primary care annual review updates health risks, prevention, chronic conditions, medicines, function, and follow-up rather than ordering every test yearly.
Health policy, systems, and equity
What a Plain-Language Summary Must Contain
An EU clinical-trial lay summary must identify the trial, explain its design and participants, and report benefits, harms, results, and follow-up clearly.
Diabetes and metabolic health
What a Phase 2 to Phase 3 Transition Decides
Moving from phase 2 to phase 3 fixes far more than a trial number. It selects the dose, population, endpoints, comparator, and evidence strategy.
Evidence and research methods
What a P Value Really Means
A p value measures how unusual a result is under a stated statistical model. It is not the probability that a hypothesis is true.
Health policy, systems, and equity
What a Notified Body Does
A notified body assesses whether certain medical devices meet EU conformity requirements. Learn its powers, limits, and role after certification.
Evidence and research methods
What a Normal Lab Reference Range Really Means
A lab reference interval describes results in a defined reference population. It is not a universal border between health and disease.
Evidence and research methods
What a Nonsignificant Result Does and Does Not Show
A practical guide to confidence intervals, power, equivalence tests, and the difference between no evidence of effect and evidence of no effect.
Evidence and research methods
What a Negative Control Tells You
A negative control asks a related question whose causal answer should be null, helping reveal confounding, selection, measurement, or analytic bias.
Diabetes and metabolic health
What a Medical Manager Does in Global Drug Development
A neutral map of the medical-manager function across evidence strategy, trial design, safety interpretation, governance, and regional coordination.
Kidney, digestive, and blood health
What a Low Platelet Count Does and Does Not Mean
How clinicians confirm thrombocytopenia, distinguish immune thrombocytopenia from urgent alternatives, and interpret bleeding risk and treatment evidence.
Evidence and research methods
What a Funnel Plot Shows, and What It Cannot
Learn how a funnel plot displays small-study effects, why asymmetry has several causes, and when visual or statistical tests are informative.
Diabetes and metabolic health
What a Euglycemic Clamp Can Show About Basal Insulin
A euglycemic clamp maps basal insulin action under controlled conditions, but it cannot by itself prove better glucose outcomes or fewer low-glucose events.
Digital health and AI
What a Decision Threshold Does in a Clinical Model
A decision threshold turns a predicted risk into an action and encodes how a clinical setting weighs missed cases against unnecessary intervention.
Heart, lung, and acute care
What a Coronary Calcium Score Means
A coronary calcium score measures calcified coronary plaque and can refine preventive treatment decisions when estimated cardiovascular risk is uncertain.
Evidence and research methods
What a Control Group Really Does
A control group estimates what would happen without the tested intervention and defines the comparison a study can legitimately claim.
Evidence and research methods
What a Confidence Interval Is Not
A confidence interval describes estimate precision under a model. It is not the probability that a claim is true or that one result will repeat.
Diabetes and metabolic health
What a Clinical Study Report Contains
A clinical study report links one trial's protocol, conduct, analyses, efficacy, safety, and participant-level support in a reviewable record.
Chronic disease in primary care
What a Clinical Red Flag Actually Predicts
Red flags update a probability; they do not diagnose by themselves. Learn how prevalence, likelihood ratios, combinations, and safety-netting work.
Skin, musculoskeletal, and eye health
Weekend Warrior Activity: What the Evidence Shows
Weekend warrior activity is linked with health benefits similar to activity spread across the week when total weekly volume is comparable.
Brain, aging, and sleep health
VO2max and Mortality: What the Association Means
VO2max strongly predicts mortality, but cohort studies cannot prove that raising one person's score will extend that person's life.
Evidence and research methods
Vaccine Science: How Evidence Is Built Before and After Authorization
How laboratory work, clinical trials, regulatory review, recommendations, safety surveillance, and causal assessment fit together.
Diabetes and metabolic health
Turn Organ-Function Pharmacokinetics Into Defensible Dosing
Connect renal and hepatic function, drug disposition, study design, unbound concentrations, modeling, clinical response, and labeling decisions.
Kidney, digestive, and blood health
Thrombophilia Testing: Why a Larger Panel May Not Improve the Decision
When inherited and acquired clotting tests can change care, when they add little, and why clot context and assay timing matter.
Evidence and research methods
The Win Ratio: Reading Hierarchical Composite Endpoints
How win-ratio analyses rank outcomes, compare patient pairs, handle ties and censoring, and sometimes hide which component drives a result.
Evidence and research methods
The Spectrum Effect: Why Test Accuracy Shifts With Case Mix
Sensitivity and specificity can change across severity, alternatives, settings, and pathways. Learn how spectrum effects alter diagnostic accuracy.
Mental and behavioral health
The Serotonin Hypothesis of Depression Reappraised
A 2022 umbrella review challenged the simple low-serotonin theory. Learn why causation, drug mechanism, and antidepressant efficacy are separate questions.
Prevention, nutrition, and travel health
The Science of Vitality and Energy
Fatigue is not one biological deficit. Sleep, mood, medicines, iron, thyroid function, and chronic illness can all shape how energy feels.
Diabetes and metabolic health
The Liver and Blood Sugar
How the liver stores, makes, and releases glucose across meals, fasting, exercise, diabetes, and liver disease.
Evidence and research methods
The Limits of a Single Study
Why one study rarely settles a scientific question, how chance and bias shape results, and how replication and synthesis strengthen conclusions.
Health policy, systems, and equity
The IVDR in Plain Language
A practical guide to the European Union's in vitro diagnostic regulation, including risk classes, evidence, notified bodies, and lifecycle duties.
Diabetes and metabolic health
The Incretin Effect Explained
Why oral glucose produces a larger insulin response than matched intravenous glucose, what GIP and GLP-1 do, and how type 2 diabetes changes the physiology.
Evidence and research methods
The Imperfect Reference Standard Problem
Diagnostic accuracy is measured against a reference standard. When that standard makes errors, sensitivity and specificity can mislead.
Physician-scientist and medical humanities
The History of Evidence-Based Medicine
Evidence-based medicine grew from fair treatment comparisons, clinical epidemiology, systematic reviews, critical appraisal, and shared decisions.
Evidence and research methods
The Hierarchy of Evidence, Explained
Evidence hierarchies rank designs by the biases they usually control, but the right design depends on the question and quality still matters.
Kidney, digestive, and blood health
The Gut-Liver Axis, Explained
The gut and liver exchange nutrients, bile acids, microbial products, and immune signals. The gut-liver axis explains the route, not a single disease.
Diabetes and metabolic health
The Gut Microbiome and Diabetes
Gut microbes and their metabolites are linked with diabetes, but medicines, diet, geography, and disease itself complicate cause and effect.
Evidence and research methods
The Fragility Index, Explained
The fragility index counts outcome changes needed to cross a significance threshold. It is intuitive, narrow, and easy to overinterpret.
Physician-scientist and medical humanities
The First Randomized Controlled Trial
The 1948 MRC streptomycin study became a landmark because random allocation, concealment, concurrent controls, and blinded assessment worked together.
Evidence and research methods
The File Drawer Problem
When studies stay unpublished because of their results, the visible literature can exaggerate benefits and hide uncertainty. Here is how to detect it.
Health policy, systems, and equity
The FDA De Novo Pathway, Explained
The FDA De Novo pathway classifies certain novel medical devices as class I or II when no suitable predicate exists and controls can manage the risks.
Chronic disease in primary care
The Evidence Behind Restrictive Blood Transfusion
Restrictive red-cell transfusion thresholds reduce transfusions without worse outcomes for many stable patients, but important exceptions remain.
Physician-scientist and medical humanities
The Ethics of Uncertainty in Medicine
Medical decisions rarely come with certainty. Ethical care makes uncertainty explicit, quantifies it when possible, and builds a plan around it.
Evidence and research methods
The Estimand Framework, Explained
An estimand states the exact treatment effect a trial seeks, including population, treatment, endpoint, later events, and summary measure.
Health policy, systems, and equity
The Economics of Prevention: Cost-Saving Is Not the Same as Cost-Effective
Prevention can improve health without saving money. Value depends on effectiveness, costs, time horizon, baseline risk, and who pays.
Evidence and research methods
The Ecological Fallacy: Keep the Claim at the Level of the Data
Why associations among countries, counties, or hospitals cannot automatically describe the people within them, and when group data remain useful.
Diabetes and metabolic health
The Discovery of Diabetes Risk Genes
Diabetes genetics moved from families and candidate genes to GWAS, sequencing, fine-mapping, diverse cohorts, and functional studies of beta cells.
Digital health and AI
The Difference Between Validation and Marketing
Validation tests a product claim under defined conditions. Marketing translates evidence into a message that can be accurate, selective, or misleading.
Chronic disease in primary care
The Diagnostic Timeout: A Structured Pause Against Premature Closure
A diagnostic timeout is a brief, structured reassessment of the working diagnosis, disconfirming data, alternatives, next tests, and follow-up plan.
Chronic disease in primary care
The Diagnostic Logic of Hyponatremia
Hyponatremia is a water-balance problem with many causes. A structured approach uses tonicity, urine osmolality, urine sodium, symptoms, and context.
Diabetes and metabolic health
The Dawn Phenomenon, Explained
Morning glucose can rise before breakfast because circadian signals increase liver glucose output. Learn how to identify the pattern and its mimics.
Evidence and research methods
The Counterfactual Idea in Causal Inference
Causal questions compare what happened with what would have happened under another action. Learn potential outcomes, assumptions, and target trials.
Digital health and AI
The Cost of a False Positive
False positives can trigger repeat tests, procedures, anxiety, labeling, alert burden, and delayed care. Their real cost depends on the full workflow.
Health policy, systems, and equity
The Common Rule and How IRBs Work
A plain-language guide to 45 CFR 46, human-subject research, IRB review, consent, exemptions, expedited review, and single-IRB reliance.
Prevention, nutrition, and travel health
The Biology of Weight Regulation, Explained
Body weight reflects dynamic feedback among brain circuits, hormones, energy expenditure, genes, medicines, sleep, food access, and environment.
Brain, aging, and sleep health
The Biology of Aging, Explained
The 12 hallmarks of aging organize molecular change, but they are not a longevity score. Learn what human trials, aging clocks, and geroscience can show.
Brain, aging, and sleep health
The Amyloid Hypothesis: Explained and Tested
Genetics, biomarkers, failed trials, lecanemab, and donanemab have all tested the amyloid hypothesis. Here is what the evidence supports and what remains open.
Diabetes and metabolic health
The Alpha Cell and Glucagon
Pancreatic alpha cells do more than oppose insulin. Learn how glucagon coordinates liver glucose, amino acids, fasting, exercise, and hypoglycemia.
Women's, men's, and reproductive health
The 2025 Testosterone Label Change, Updated for 2026
FDA removed cardiovascular boxed-warning language and added blood-pressure warnings in 2025, then requested more label changes in June 2026.
Diabetes and metabolic health
Testosterone Assay Pitfalls: Why One Number Is Not a Diagnosis
Testosterone results vary with timing, illness, SHBG, assay method, and reference range. Learn why repeat morning testing and clinical context matter.
Brain, aging, and sleep health
Tenecteplase Versus Alteplase: How the Noninferiority Trials Read
Multiple stroke trials found tenecteplase noninferior to alteplase. Learn what the margins, outcomes, populations, doses, and safety results actually establish.
Skin, musculoskeletal, and eye health
Teledermatology Diagnostic Accuracy: What the Evidence Shows
Teledermatology can expand access, but accuracy depends on the question, images, history, and reference standard. Learn how to read concordance and cancer data.
Heart, lung, and acute care
TAVR Versus SAVR in Low-Risk Aortic Stenosis
Low surgical risk does not make TAVR and surgery interchangeable. Learn how long-term trials, anatomy, valve durability, and lifetime planning shape the choice.
Evidence and research methods
Target Trial Emulation Explained
Target trial emulation starts with the randomized trial researchers wish they could run, then maps that protocol transparently to observational data.
Evidence and research methods
Surrogate Endpoints Versus Outcomes That Matter
A biomarker can shorten a trial without guaranteeing patient benefit. Learn validation, trial-level prediction, failure modes, and confirmatory evidence.
Medicines and drug development
SURMOUNT-1: How to Read a Weight-Loss Trial
SURMOUNT-1 reported large average weight reductions with tirzepatide. Learn how population, estimands, missing data, harms, and follow-up shape the result.
Prevention, nutrition, and travel health
Supplements: What Helps, What Is Hype, and What Can Harm
An evidence-first guide to supplement benefits, uncertain claims, interactions, contamination, dosing, and safer decisions.
Prevention, nutrition, and travel health
Supplement Contamination and Inadvertent Doping Risk
A supplement label may not match its contents. Learn how strict liability, prohibited lists, batch testing, and documentation shape athlete risk.
Skin, musculoskeletal, and eye health
Sunscreen Ingredient Absorption: What Systemic Detection Means
Maximal-use trials detected sunscreen ingredients in blood. Detection triggers further safety testing; it does not by itself demonstrate clinical harm.
Diabetes and metabolic health
Subclinical Hypothyroidism: Where Treatment Thresholds Come From
Mildly high TSH with normal free T4 is common and can be transient. Treatment decisions depend on persistence, age, context, symptoms, and evidence.
Evidence and research methods
Statistical Significance vs Clinical Importance
A p-value addresses compatibility with a statistical model. Clinical importance depends on effect size, uncertainty, baseline risk, harms, burden, and values.
Heart, lung, and acute care
Statin Intolerance and the Nocebo Effect
Blinded n-of-1 trials show that symptoms are real while their timing often cannot distinguish statin effects from placebo and background symptoms.
Evidence and research methods
SPRINT: What Intensive Blood-Pressure Treatment Proved
SPRINT lowered cardiovascular events and mortality in selected high-risk adults. Learn its targets, measurement protocol, harms, and limits.
Health policy, systems, and equity
Software as a Medical Device After Launch: The Evidence Loop
Launch is the start of medical-device software oversight. Learn how monitoring, complaints, incidents, updates, and change control fit together.
Health policy, systems, and equity
Social Determinants of Health: The Factors Outside the Clinic
How housing, food, income, education, transportation, environment, and social context shape health and health care.
Evidence and research methods
Small-Study Effects: Egger's Test and Trim-and-Fill
Funnel-plot asymmetry can have many causes. Learn what Egger's test and trim-and-fill estimate, their assumptions, and safer interpretation.
Brain, aging, and sleep health
Sleep Hygiene That Works: Screens, Caffeine, and Timing
Rank practical sleep habits by mechanism, test changes realistically, and know when sleep hygiene is not enough to treat a sleep disorder.
Prevention, nutrition, and travel health
Sleep as a Foundation of Health: More Than Hours
Healthy sleep includes duration, regularity, timing, continuity, daytime function, and freedom from sleep disorders, not just hours in bed.
Brain, aging, and sleep health
Sleep Apnea Signs: What Should Prompt an Evaluation?
Snoring is only one clue. Learn which sleep-apnea signs, risk patterns, daytime effects, and test results deserve clinical evaluation.
Mental and behavioral health
Sleep and Mental Health: What the Causal Evidence Shows
Sleep and mental health influence each other. Randomized trials show what improving sleep can change, while clarifying important limits.
Skin, musculoskeletal, and eye health
Skin Cancer in Skin of Color: What the Evidence Shows
Skin cancer occurs in every skin tone. Learn how patterns, warning signs, diagnostic delay, and evidence limits differ in darker skin.
Evidence and research methods
Single-Blind, Double-Blind, and Open Peer Review: What Trials Show
Randomized journal trials tested masked authors, signed reviews, and public reports. Their narrow results do not settle whether peer review works overall.
Prevention, nutrition, and travel health
Sick Days and Diabetes: Why a Plan Made in Advance Matters
Illness can raise or lower glucose and increase dehydration, ketone, and medication risks. A written diabetes sick-day plan makes the response safer.
Brain, aging, and sleep health
Shift Work and Sleep: Practical Risk Reduction
A practical plan for shift-work sleep, light, naps, caffeine, commuting, rotations, fatigue reporting, and when symptoms need care.
Women's, men's, and reproductive health
Sex Differences in Pharmacology: The Zolpidem Lesson
The FDA lowered zolpidem starting doses for women after finding slower clearance and morning impairment risk. Learn what the case does and does not prove.
Infection, immunity, and cancer
Sepsis Versus Infection: What Sepsis-3 Changed
Sepsis-3 centers life-threatening organ dysfunction, not infection alone. Learn how SOFA, qSOFA, SIRS, and septic shock fit current evidence.
Skin, musculoskeletal, and eye health
Sentinel Node Biopsy in Melanoma: What Trials Show
Sentinel node biopsy stages melanoma. Learn what MSLT-I and MSLT-II showed about prognosis, completion dissection, survival, and lymphedema.
Evidence and research methods
Sensitivity and Specificity: A Practical Guide
Learn how sensitivity, specificity, predictive values, prevalence, thresholds, and likelihood ratios change the meaning of a diagnostic test.
Brain, aging, and sleep health
Senolytics and Cellular Senescence: Evidence Check
Human senolytic trials remain early. Learn what cellular senescence is, what small trials show, and why animal results do not prove healthier aging.
Brain, aging, and sleep health
Sarcopenia: How Muscle Loss Became a Diagnosis
Learn how sarcopenia definitions combine muscle strength, muscle quantity, and physical performance, and why thresholds differ across groups.
Evidence and research methods
Sample Size for Developing a Prediction Model
The ten-events-per-variable rule is not enough. Learn how shrinkage, outcome frequency, predictor parameters, and precision guide model sample size.
Health policy, systems, and equity
SaMD: Analytical Versus Clinical Validation
Learn how valid clinical association, analytical validation, and clinical validation support a Software as a Medical Device claim.
Skin, musculoskeletal, and eye health
Rosacea Treatment by Phenotype and Evidence
An evidence-based map from rosacea features to skin care, topical and oral therapies, procedures, and ocular or phymatous referral.
Physician-scientist and medical humanities
Risk Stratification in Diabetes Prevention
How screening, prediction, risk tiers, and treatment-effect evidence can make type 2 diabetes prevention more precise and equitable.
Health policy, systems, and equity
Risk Management Plans and Additional Risk Minimization
How EU risk management plans connect safety concerns, pharmacovigilance, routine controls, additional measures, and effectiveness evaluation.
Health policy, systems, and equity
Risk Management in Medical Software
How ISO 14971 and IEC 62304 connect hazards, requirements, software life-cycle controls, testing, cybersecurity, and postmarket learning.
Evidence and research methods
Risk Enhancers in a Statin Decision
How the 2026 dyslipidemia guideline combines PREVENT risk, risk enhancers, Lp(a), apoB, and coronary calcium in primary prevention.
Medicines and drug development
Retatrutide Phase 2, Phase 3, and Approval
What retatrutide's phase 2 trial established, what 2026 phase 3 topline results add, and why neither a headline nor one trial is FDA approval.
Evidence and research methods
Restricted Mean Survival Time, Explained
Restricted mean survival time reports average event-free time through a chosen horizon and remains interpretable when hazards are not proportional.
Kidney, digestive, and blood health
Resmetirom and Accelerated Approval for MASH
How resmetirom became the first FDA-approved MASH treatment, what its biopsy endpoints showed, and what accelerated approval still requires.
Evidence and research methods
Research With Vulnerable Populations and Extra Protections
How research ethics turns contextual vulnerability into added safeguards while avoiding unjustified exclusion from evidence and benefits.
Medicines and drug development
Research Peptides Online: Regulation and Evidence
What FDA approval, research-only labeling, and the 503A compounding process mean for BPC-157, TB-500, and other online peptides in July 2026.
Evidence and research methods
Research Misconduct, Questionable Practices, and Honest Error
How current US policy distinguishes fabrication, falsification, and plagiarism from detrimental practices, disagreement, and honest error.
Evidence and research methods
Reproducibility Versus Replicability
A practical guide to computational reproducibility, new-data replication, terminology differences, and what each can and cannot establish.
Evidence and research methods
Reproducibility in Diabetes Research
A diabetes-specific guide to reproducible analysis, replication, assay harmonization, CGM definitions, transparent protocols, and data sharing.
Digital health and AI
Reporting Standards for Medical AI
How current reporting guidelines make medical AI claims checkable across prediction, diagnosis, trials, imaging, and early clinical evaluation.
Evidence and research methods
Reporting Guidelines, CONSORT 2025, and the EQUATOR Network
How CONSORT 2025 and the EQUATOR Network make health research checkable, and why complete reporting does not guarantee a sound study.
Evidence and research methods
Relative Risk Versus Odds Ratio
Relative risk compares probabilities; an odds ratio compares odds. They are similar for rare outcomes and can diverge sharply for common outcomes.
Skin, musculoskeletal, and eye health
Relative Energy Deficiency in Sport Explained
REDs is a multisystem syndrome linked to problematic low energy availability. Learn the signs, assessment limits, risk model, and recovery principles.
Health policy, systems, and equity
Regulation as a Design Input for Medical Software
Start medical software with the intended use, claim, hazards, and evidence plan. A regulatory-first workflow turns obligations into testable specifications.
Evidence and research methods
Regression to the Mean in Health and Research
Extreme measurements often move toward average on repeat testing. Learn why this happens, how it mimics treatment benefit, and how studies control it.
Chronic disease in primary care
Reading the Workup of an Overactive Thyroid
A structured guide to confirming thyrotoxicosis and distinguishing Graves disease, thyroiditis, nodules, medicines, and assay interference.
Chronic disease in primary care
Reading the Workup for Adrenal Insufficiency
A structured guide to adrenal insufficiency testing, including morning cortisol, ACTH, stimulation tests, assay limits, causes, and emergencies.
Evidence and research methods
Reading the Esketamine Evidence for Treatment-Resistant Depression
What esketamine trials show about rapid symptom change, monotherapy, relapse prevention, masking, selected populations, safety, and regulatory limits.
Kidney, digestive, and blood health
Reading the 4Ts Score for Heparin-Induced Thrombocytopenia
How the 4Ts score estimates pretest probability of HIT from platelet fall, timing, thrombosis, and alternative causes, and how it guides laboratory testing.
Evidence and research methods
Reading Nonrandomized Studies With ROBINS-I
A practical guide to target trials, confounding, immortal time, result-level judgments, and the draft six-domain ROBINS-I V2.
Health policy, systems, and equity
Reading FDA Adverse Event Signals: From FAERS to AEMS
What spontaneous safety reports and disproportionality analyses can show, why they cannot estimate risk, and how FDA investigates a signal.
Evidence and research methods
Reading an Objective Response Rate in a Cancer Study
How objective response rate is defined, measured, confirmed, and interpreted alongside duration, independent review, missing scans, safety, and survival.
Evidence and research methods
Reading a Trial That Missed Its Endpoint: The Lactate Question in Septic Shock
What ANDROMEDA-SHOCK tested, why its primary mortality result was negative, what the confidence interval permits, and how later evidence should be separated.
Imaging and radiology
Reading a PI-RADS Score: What Prostate MRI Can and Cannot Tell You
How PI-RADS v2.1 classifies prostate MRI lesions, what categories 1 through 5 mean, and why PSA density, MRI quality, history, and biopsy still matter.
Evidence and research methods
Reading a Network Meta-Analysis and the Transitivity Assumption
How network meta-analysis combines direct and indirect comparisons, why transitivity is essential, and why treatment rankings can overstate certainty.
Evidence and research methods
Read Trials on the Pragmatic-Explanatory Continuum
Interpret pragmatic and explanatory trials by matching eligibility, setting, delivery, follow-up, outcomes, and analysis to the study purpose.
Health policy, systems, and equity
Read a PBRER as a Traceable Benefit-Risk Decision
Understand how a PBRER integrates interval and cumulative safety, use, signals, benefits, uncertainties, and actions without delaying urgent reporting.
Infection, immunity, and cancer
Rapid Antigen vs PCR: Why the Same Person Can Test Both Ways
How antigen and molecular tests detect viruses, why results can disagree, and how timing, symptoms, specimens, and purpose change interpretation.
Brain, aging, and sleep health
Rapamycin for Aging: What Human Trials Actually Show
A critical review of human rapamycin and rapalog trials for aging-related outcomes, including PEARL, immune studies, safety limits, and unanswered questions.
Prevention, nutrition, and travel health
Questions to Bring to a Diabetes Appointment
A practical guide to preparing for a diabetes visit and asking about glucose goals, medicines, complications, technology, prevention, and barriers to care.
Evidence and research methods
Quantifying Heterogeneity: What I-Squared and Tau-Squared Each Mean
How I-squared, tau-squared, Cochran's Q, and prediction intervals describe different parts of between-study variation in a meta-analysis.
Diabetes and metabolic health
Quality by Design in Clinical Trials: Applying ICH E8(R1) Critical-to-Quality Factors
How ICH E8(R1) defines fitness for purpose, identifies critical-to-quality factors, and uses proportionate risk controls across a trial.
Evidence and research methods
QUADAS-2 and QUADAS-3: How to Judge Bias in Diagnostic Accuracy Studies
How QUADAS-2's four domains identify bias in diagnostic studies, and what changed when QUADAS-3 became the recommended version in 2026.
Evidence and research methods
Publication Bias in Antidepressant Trials: What the FDA Record Revealed
How Turner compared FDA records with journal articles, quantified selective publication, and showed why trial registries matter.
Skin, musculoskeletal, and eye health
Psoriasis as a Systemic Disease: How Strong Is the Cardiovascular Evidence?
Why psoriasis is associated with cardiovascular disease, what causal studies can and cannot show, and how guidelines approach risk screening.
Imaging and radiology
PSMA PET for Prostate Cancer Staging: What proPSMA Proved and What It Did Not
How proPSMA compared PSMA PET-CT with CT plus bone scan for high-risk prostate cancer, including accuracy, management change, and limits.
Women's, men's, and reproductive health
PSA Screening: Why ERSPC and PLCO Reached Different Conclusions
How ERSPC and PLCO differed in control-group screening, follow-up, and design, and why PSA screening remains a preference-sensitive decision.
Skin, musculoskeletal, and eye health
PRP for Hair Loss: How Strong Is the Evidence?
What randomized trials and recent meta-analyses show about PRP for pattern hair loss, including heterogeneity, protocol variation, and safety gaps.
Skin, musculoskeletal, and eye health
Protecting Your Vision: An Eye-Health Primer
A whole-life guide to eye exams, vision changes, injury prevention, contact-lens safety, and urgent warning signs.
Women's, men's, and reproductive health
ProtecT at 15 Years: Active Monitoring, Surgery, and Radiotherapy Compared
What ProtecT found at 15 years about prostate cancer death, metastasis, progression, treatment crossover, and quality-of-life tradeoffs.
Digital health and AI
Prospective vs Retrospective Validation in Clinical AI: What Each Design Proves
How retrospective, prospective silent-mode, and interventional studies answer different questions about clinical AI performance and value.
Evidence and research methods
Propensity Scores Explained: Balance, Overlap, and the Confounding They Cannot Fix
How propensity scores support observational comparisons through matching or weighting, and how to audit balance, overlap, and residual bias.
Diabetes and metabolic health
Project Optimus: Why Oncology Dose Finding Moved Beyond the Maximum Tolerated Dose
How FDA Project Optimus reframed cancer-drug dose selection around benefit, tolerability, pharmacology, and randomized dose comparisons.
Diabetes and metabolic health
Primary Hyperparathyroidism: How Calcium and PTH Establish the Pattern
How calcium and PTH establish primary hyperparathyroidism, what mimics it, and why urine, kidney, and bone findings complete the assessment.
Diabetes and metabolic health
Primary Aldosteronism: Why Hypertension Screening Expanded
Why primary aldosteronism is often missed, how aldosterone and renin screening works, what affects the ratio, and how confirmation and subtype guide care.
Chronic disease in primary care
Preventive Care Has a Clock: Understanding Time to Benefit
Time to benefit estimates when a preventive intervention begins producing enough absolute benefit to matter, while burdens may begin immediately.
Evidence and research methods
PREVENT Equations Versus Pooled Cohort Equations: What Changed and Why
How PREVENT differs from the Pooled Cohort Equations in population, outcomes, inputs, race, kidney measures, time horizon, calibration, and guideline use.
Evidence and research methods
Prespecified Versus Post Hoc Analyses: How to Judge the Difference Fairly
How protocols, registries, and statistical analysis plans constrain flexibility, when deviations are legitimate, and why post hoc findings can still be useful.
Chronic disease in primary care
Prescribing Cascades: When a Medication Side Effect Is Treated as a New Disease
How prescribing cascades begin, why they are missed, which clues reveal them, and how clinicians can review the original and added medicines safely.
Evidence and research methods
Prediction Model Impact Studies Versus Validation: The Evidence Gap That Matters
Why good predictive performance does not prove clinical benefit, and how impact studies test workflow, decisions, outcomes, harms, cost, and equity.
Evidence and research methods
Prediction Intervals in Meta-Analysis: What They Add Beyond a Confidence Interval
How prediction intervals describe between-study heterogeneity, why they differ from confidence intervals, and when their apparent precision can mislead.
Digital health and AI
Predetermined Change Control Plans for AI Medical Devices: A Practical Guide
How a PCCP can authorize bounded future changes to an AI-enabled medical device, and what reviewers should expect from its methods, safeguards, and monitoring.
Evidence and research methods
Precision Versus Accuracy in Measurement: A Clinical Research Guide
A practical guide to accuracy, trueness, precision, repeatability, reproducibility, bias, uncertainty, calibration, and traceability in clinical measurement.
Physician-scientist and medical humanities
Precision Medicine in Diabetes: Where It Changes Care and Where Evidence Is Still Thin
A framework for precision diabetes medicine across diagnosis, prevention, treatment, and prognosis, including utility, fairness, and evidence gaps.
Evidence and research methods
Post-Publication Peer Review: How Scientific Critique Continues After Publication
How comments, corrections, expressions of concern, and retractions work after publication, plus a practical method for weighing public criticism.
Evidence and research methods
Peer Review and Preprints: What Review Can and Cannot Catch
Peer review adds expert scrutiny but cannot certify truth, integrity, or replication. Learn how to weigh preprints, revisions, and corrections.
Chronic disease in primary care
Pay for Performance in Primary Care: What the Quality Evidence Actually Shows
A guide to primary-care pay for performance, including process gains, uncertain patient outcomes, gaming risks, equity, and withdrawal evidence.
Evidence and research methods
One Health, Climate, and Health: A Framework for Connected Risks
How human, animal, plant, and environmental systems interact, how climate shapes health pathways, and how to interpret risk without overclaiming causation.
Evidence and research methods
NRI and IDI Reclassification Metrics, and Their Pitfalls
NRI and IDI can describe changes between prediction models, but calibration, thresholds, optimism, and clinical utility determine whether changes matter.
Digital health and AI
Monitoring Medical AI Performance After Deployment
A practical framework for monitoring medical AI after deployment, including drift, subgroup performance, workflow, updates, safety, and action thresholds.
Digital health and AI
Monitoring a Clinical Model After Deployment
Clinical model monitoring links data, performance, workflow, subgroup, and safety signals to predefined investigation and response paths.
Evidence and research methods
Missing Trial Data Are an Assumption Problem, Not an Empty-Cell Problem
Missing trial outcomes can change an estimate when absence relates to health or treatment. Imputation and sensitivity analyses make assumptions visible.
Evidence and research methods
Meta-Research Measures How Science Is Produced, Checked, and Rewarded
Meta-research studies research methods, reporting, verification, evaluation, and incentives so scientific reform can be tested with evidence.
Evidence and research methods
Meta-Regression Explains Differences Between Studies, Not Between People
Meta-regression relates study features to effect estimates, but ecological bias and sparse study counts limit individual-level conclusions.
Evidence and research methods
Medication Safety and Adherence: A Practical System for Safer Use
How medication lists, reconciliation, interaction checks, barrier-aware adherence support, and clear follow-up reduce preventable harm.
Physician-scientist and medical humanities
Medical Ethics in Everyday Care: Four Principles
Autonomy, beneficence, non-maleficence, and justice explained through everyday care, competing duties, and a practical reasoning process.
Evidence and research methods
Mediation Analysis Tests a Pathway, but the Pathway Is Not Randomized
Mediation analysis separates direct and indirect effects, but causal interpretation depends on timing, measurement, and confounding assumptions.
Diabetes and metabolic health
Linkage and Association in Genetics: Different Evidence, Different Scale
A rigorous comparison of family linkage, genetic association, recombination, linkage disequilibrium, causal inference, and study limitations.
Evidence and research methods
Is This Systematic Review Still Current?
Judge systematic review currency from its last search, new evidence, current question, methods, certainty, and update process.
Prevention, nutrition, and travel health
Intermittent Fasting and the Evidence: A Trial-by-Trial Reading Guide
What randomized trials show about time-restricted eating, weight, and glucose, why study designs differ, and where safety planning matters.
Brain, aging, and sleep health
Insomnia: What Actually Helps, with CBT-I First
Why CBT-I is first-line care for chronic insomnia, what it contains, where sleep habits fit, and when medicines or testing may help.
Evidence and research methods
Individual Participant Data Meta-Analysis: What the Raw Records Add
How IPD meta-analysis checks and harmonizes participant records, preserves trial structure, studies effect modifiers, and handles missing data sets.
Prevention, nutrition, and travel health
Hydration and Salt: Separating Fact from Myth
How water needs, thirst, food moisture, sodium guidance, heat, exercise, and medical conditions change sensible hydration choices.
Chronic disease in primary care
How X-ray, CT, Ultrasound, and MRI Build Medical Images
How four imaging modalities create information, what limits each signal, and why the clinical question determines the appropriate examination.
Chronic disease in primary care
How Type 2 Diabetes Therapy Is Intensified Under Current Guidelines
How 2026 guidance integrates glucose, weight, heart, kidney, liver, hypoglycemia, cost, and treatment burden when therapy changes.
Evidence and research methods
How Trials Report Harms, and Why the Safety Half Is Often Thin
How to appraise event definitions, collection, denominators, recurrence, time at risk, withdrawals, coding, missing data, and rare harms in trials.
Kidney, digestive, and blood health
How to Read the SGLT2 Inhibitor Kidney Trials
DAPA-CKD and EMPA-KIDNEY changed kidney care. This guide explains composite outcomes, eGFR slope, eligibility, benefits, and harms.
Mental and behavioral health
How to Read Psilocybin Depression Trials Without the Hype
Psilocybin depression trials show a signal, but masking, support, selection, short follow-up, and safety shape what that signal means.
Evidence and research methods
How to Read Image-Integrity Concerns in Research Papers
How duplicated, spliced, or selectively adjusted figures are detected, investigated, and interpreted without assuming intent.
Evidence and research methods
How to Read Antidepressant Effect Sizes Without Overclaiming
How mean differences, standardized effects, response odds, placebo change, duration, and reporting bias shape antidepressant evidence.
Digital health and AI
How to Read an ROC Curve Without Being Misled by the AUC
How ROC thresholds trade sensitivity for specificity, what AUC measures, and why calibration, validation, prevalence, and utility still matter.
Evidence and research methods
How to Read an N-of-1 Trial: A Randomized Experiment for One Person
How repeated treatment periods, randomization, blinding, washout, outcomes, and analysis turn one person's treatment comparison into evidence.
Evidence and research methods
How to Read a Stepped-Wedge Trial When Treatment and Time Move Together
How randomized rollout, secular trends, clustering, transition periods, and time-adjusted analysis determine a stepped-wedge result.
Women's, men's, and reproductive health
How to Read a Semen Analysis and the WHO Reference Limits
How collection, variation, semen volume, sperm count, motility, morphology, vitality, and WHO sixth-edition limits fit fertility evaluation.
Evidence and research methods
How to Read a RoB 2 Risk-of-Bias Assessment
How Cochrane RoB 2 assesses bias in a specific randomized-trial result across randomization, deviations, missing data, measurement, and selective reporting.
Evidence and research methods
How to Read a Responder Analysis
Responder analyses turn continuous scores into yes or no. Learn what the threshold clarifies, what information it loses, and what to check.
Evidence and research methods
How to Read a Methods Section Like a Reviewer
A practical methods-section audit for checking whether a study's design, participants, outcomes, and analysis support its claims.
Evidence and research methods
How to Read a Crossover Trial: Periods, Carryover, and Paired Evidence
How crossover trials use within-person comparisons, when washout works, and how period effects, dropout, and analysis shape validity.
Evidence and research methods
How to Read a Cluster Randomized Trial Without Overcounting the Evidence
How group randomization changes sample size, analysis, recruitment bias, estimands, and interpretation in a cluster trial.
Digital health and AI
How to Read a Calibration Plot
Learn how calibration plots compare predicted risk with observed outcomes, what the diagonal means, and why discrimination alone is not enough.
Evidence and research methods
How to Interpret an E-Value Without Overclaiming
What an E-value quantifies, how to benchmark it, and why it cannot rule out bias or turn an observational association into causation.
Evidence and research methods
How to Audit Difference-in-Differences and Interrupted Time Series Studies
A practical guide to the counterfactual assumptions, graphs, time trends, and modern checks behind two common quasi-experiments.
Digital health and AI
How to Appraise a Clinical Prediction Model
Appraise a clinical prediction model by checking its purpose, data, calibration, discrimination, transportability, and decision value.
Physician-scientist and medical humanities
How the RECOVERY Adaptive Platform Trial Worked
RECOVERY produced rapid randomized answers through a master protocol, concurrent controls, simple enrollment, large scale, and prespecified analyses.
Health policy, systems, and equity
How the Health System Is Organized, in Plain Terms
A neutral guide to how health care is delivered, financed, coordinated, and regulated, and how a patient actually gets through it.
Evidence and research methods
How Surrogate Endpoints Are Validated and Used
Why biomarker correlation is insufficient, how trial-level validation works, and how FDA distinguishes validated and reasonably likely surrogates.
Evidence and research methods
How SGLT2 Inhibitors Became Heart Failure Therapy
EMPA-REG, DAPA-HF, EMPEROR, and DELIVER moved SGLT2 inhibitors from glucose lowering to heart failure care across ejection fraction.
Health policy, systems, and equity
How Regulators Use Real-World Evidence
Real-world evidence can support product decisions when data are relevant, reliable, and analyzed for a prespecified regulatory question.
Evidence and research methods
How Overdiagnosis Is Measured, and Why the Estimates Vary
Why overdiagnosis is a population estimate, how trials, cohorts, pathology studies, and models measure it, and why denominators matter.
Brain, aging, and sleep health
How Much Sleep Do You Really Need?
Evidence-based sleep ranges by age, why individual need varies, and how duration, quality, timing, regularity, and function fit together.
Physician-scientist and medical humanities
How Insulin Became a Treatment: A Breakthrough Revisited
The insulin breakthrough as a chain of prior science, teamwork, purification, patient evidence, manufacturing, revision, and unfinished access.
Medicines and drug development
How GalNAc siRNA Medicines Silence Liver Genes
GalNAc directs siRNA to liver cells, where RNA interference lowers a chosen messenger RNA. Learn the mechanism, approved examples, and evidence limits.
Medicines and drug development
How Drug Programs Build an Integrated QT Prolongation Risk Assessment
How ion-channel studies, in vivo data, standardized ECGs, and concentration-QTc models combine to assess a medicine's QT liability.
Diabetes and metabolic health
How Drug Interaction Evidence Becomes a Medicine-Label Instruction
How laboratory studies, clinical trials, and PBPK models turn an interaction mechanism into a practical label recommendation.
Diabetes and metabolic health
How Drug Doses Are Chosen, Tested, and Adjusted
A plain-language guide to dose selection, concentration-response evidence, dose-ranging trials, labeling, and reasons a dose may need review.
Chronic disease in primary care
How Diabetes Is Diagnosed: Thresholds, Confirmation, and Discordant Tests
The four routes to a diabetes diagnosis, when confirmation is needed, why tests disagree, and when HbA1c can mislead.
Diabetes and metabolic health
How Development Safety Update Reports Keep Trial Risk Current
What a DSUR contains, how it connects cumulative safety evidence to action, and why annual reporting does not replace urgent reporting.
Evidence and research methods
How Corrections, Expressions of Concern, and Retractions Change a Paper
A guide to the notices journals use to repair the scholarly record, what each status means, and how readers can verify the current version.
Chronic disease in primary care
How Common Is Diagnostic Error, and What Do the Estimates Count?
Why diagnostic-error estimates differ, what each method detects, and how to interpret a national estimate of serious harm.
Chronic disease in primary care
How Clinicians Reason: Pattern Recognition, Analysis, and Illness Scripts
How pattern recognition, deliberate analysis, and illness scripts work together in clinical reasoning, and why each can fail.
Medicines and drug development
How Biologic Comparability Separates a Manufacturing Change From a Clinical Change
A risk-based guide to comparing biologics before and after a process change through quality, function, stability, and targeted bridging evidence.
Evidence and research methods
How Audit Trails Make Clinical-Trial Data Traceable
ICH E6(R3), ALCOA principles, metadata, and secure audit trails explain how a clinical result can be traced back to its source.
Evidence and research methods
How a Patient-Reported Outcome Measure Earns Trust: Reading It Through COSMIN
A guide to content validity, structure, reliability, error, construct validity, responsiveness, interpretability, and feasibility in PROM research.
Diabetes and metabolic health
How a Diabetes GWAS Signal Becomes a Mechanism
Follow a diabetes GWAS signal through fine-mapping, cell-specific regulation, target-gene evidence, perturbation, and functional confirmation.
Evidence and research methods
How a Clinical Prediction Model Earns Trust
How TRIPOD+AI and PROBAST+AI frame model reporting, validation, calibration, clinical utility, fairness, and transportability.
Health policy, systems, and equity
Health Literacy: Why Clear Information Changes Outcomes
How personal and organizational health literacy shape understanding, decisions, getting through the system, safety, and health outcomes.
Evidence and research methods
GRADE Imprecision: Confidence Intervals, Thresholds, and Information Size
How GRADE judges whether uncertainty crosses a decision threshold, when optimal information size matters, and why significance is not enough.
Skin, musculoskeletal, and eye health
Glaucoma Basics: Risk, Detection, and Protecting Vision
What glaucoma is, how risk and eye pressure are assessed, what screening evidence says, and how progression is monitored.
Medicines and drug development
Generic vs. Brand-Name Drugs: What Is Different?
How FDA-approved generics match brand drugs, what bioequivalence means, and when inactive ingredients, formulation, or monitoring matter.
Diabetes and metabolic health
Gene-Environment Interaction in Type 2 Diabetes: What the Evidence Can Actually Show
How researchers separate genetic susceptibility, environmental factors, joint effects, and true interaction in type 2 diabetes studies.
Diabetes and metabolic health
Gene Regulation and Type 2 Diabetes: From Association Signals to Cell-Specific Mechanisms
How noncoding variants, enhancers, chromatin maps, and functional studies help researchers interpret the genetics of type 2 diabetes.
Physician-scientist and medical humanities
From Biological Idea to Clinical Use: A Map of Translation
A regulator-grounded map from biological hypothesis and product design through preclinical work, human trials, review, manufacturing, and implementation.
Health policy, systems, and equity
FDA Cleared and FDA Approved Are Different Evidence Claims
The 510(k) pathway compares a device with a legally marketed predicate. Learn what substantial equivalence does and does not establish.
Evidence and research methods
FAIR Research Data: More Than Posting a Download Link
How identifiers, metadata, standard protocols, vocabularies, licenses, and provenance make research data usable by people and machines.
Evidence and research methods
Every Extra Trial Test Spends Some of the False-Positive Budget
Multiple endpoints, groups, time points, subgroups, and interim analyses raise false-positive risk unless a prespecified testing strategy controls it.
Skin, musculoskeletal, and eye health
Dry Eye and Screens: What Helps, What Is Known, and When to Get Care
A practical, evidence-based guide to dry eye, screen-related discomfort, blinking, work setup, contact-lens safety, and warning signs.
Evidence and research methods
Directed Acyclic Graphs: A Reader's Guide to Causal Adjustment
How causal diagrams distinguish confounders, mediators, colliders, and selection variables before statistical adjustment begins.
Prevention, nutrition, and travel health
Dietary Patterns and Metabolic Health: How to Read the Evidence
A practical evidence guide to dietary patterns, metabolic outcomes, study limitations, personalization, and safety considerations.
Evidence and research methods
Diagnostic Error and Patient Safety: Building a Safer Diagnostic Process
How diagnostic error is defined, why uncertainty is not the same as negligence, and how teams and patients can close safety gaps.
Prevention, nutrition, and travel health
Diabetes and Foot Health: A Risk-Based Guide to Prevention and Early Response
How neuropathy, circulation, pressure, and prior ulcers shape diabetes-related foot risk, with a clear framework for checks and escalation.
Prevention, nutrition, and travel health
Diabetes and Eye Health: What Screening Can Find Before Vision Changes
A plain-language guide to diabetic retinopathy, macular edema, screening, urgent symptoms, and the evidence behind early detection.
Prevention, nutrition, and travel health
Diabetes and Aging: A Framework for Safer, Individualized Care
How health status, hypoglycemia risk, function, cognition, treatment burden, nutrition, and personal priorities shape diabetes care in later life.
Evidence and research methods
Compare the Published Trial With the Outcome Plan Written Before Results
Outcome switching lets a result chosen after analysis appear prespecified. Registry histories, protocols, and analysis plans reveal what changed and when.
Evidence and research methods
Cohort or Case-Control? How Observational Designs Answer Different Questions
How sampling distinguishes cohort from case-control studies, what each estimates, and where confounding, selection, and measurement distort results.
Medicines and drug development
Clinical Trial Phases Explained: What Each Can Prove
Clinical trial phases explained by question, participants, endpoints, controls, uncertainty, approval status, and postmarket evidence.
Digital health and AI
Classify EU Medical Software by Function and Consequence
Apply EU MDR Rule 11 only after qualification, then use intended purpose, clinical function, decision consequence, and the strictest applicable rule.
Diabetes and metabolic health
Circadian Rhythm and Metabolism: Separating Clock Effects from Sleep and Meal Timing
How laboratory studies separate circadian phase, sleep-wake timing, and meals when testing glucose regulation, plus the limits of the evidence.
Medicines and drug development
Choosing a First-in-Human Starting Dose Without Treating One Formula as the Answer
A decision framework for selecting a first-in-human dose from toxicology, pharmacology, human predictions, uncertainty, and trial controls.
Skin, musculoskeletal, and eye health
Cataracts: What They Are and When to Act
A practical guide to cataract symptoms, diagnosis, timing of surgery, lens decisions, recovery, and warning signs.
Skin, musculoskeletal, and eye health
Can a Smartphone App Detect Melanoma? The Accuracy Evidence
Studies found wide and sometimes unsafe variation in melanoma-app accuracy. Learn why version, setting, reference standard, and intended use matter.
Health policy, systems, and equity
Building an IVD Performance Evaluation From Claim to Lifecycle Evidence
How an IVD intended purpose becomes a traceable evidence plan spanning scientific validity, analytical performance, and clinical performance.
Evidence and research methods
Build Model-Informed Drug Development Around the Decision
Use ICH M15 to connect a drug-development question, context of use, model risk, evaluation criteria, reporting, and a bounded decision claim.
Prevention, nutrition, and travel health
Blood Pressure and Diabetes: Reading Risk Across the Heart, Kidneys, Eyes, and Feet
How blood pressure changes cardiovascular and microvascular risk in diabetes, what accurate measurement shows, and why organ checks matter.
Evidence and research methods
Bayesian and Frequentist Trial Results Answer Different Questions
How to interpret p values, confidence intervals, priors, posterior probabilities, and credible intervals without mixing the frameworks.
Evidence and research methods
Allocation Concealment and Blinding Guard Different Parts of a Trial
Allocation concealment protects random assignment before it occurs; blinding limits biased behavior and assessment afterward.
Evidence and research methods
A Subgroup Result Needs an Interaction Test, Not Two Separate P Values
ICEMAN helps readers judge whether an apparent treatment difference across patient groups is credible rather than a chance finding.
Chronic disease in primary care
A Safer Way to Read a Radiology Report
How to identify the question, comparison, limitations, impression, and follow-up in an imaging report without trying to self-diagnose.
Diabetes and metabolic health
A Nocturnal Hypoglycemia Endpoint Needs a Threshold, Clock, and Denominator
Nocturnal hypoglycemia results depend on glucose thresholds, nighttime windows, measurement methods, episode rules, and observation-time denominators.
Evidence and research methods
A Living Systematic Review Is a Maintained Evidence System
Living reviews use continual surveillance, explicit update triggers, and version control to keep high-priority evidence syntheses current.
Evidence and research methods
A Clinically Important Difference Is Not Just a Significant Difference
The minimal clinically important difference connects a score change to patient importance, but its value depends on context, anchors, and uncertainty.
Evidence and research methods
Why the Same Test Result Means Different Things in Different Patients
How pretest probability, likelihood ratios, and the Fagan nomogram show why one lab result can mean certainty in one patient and little in another
Skin, musculoskeletal, and eye health
Why the Osteoarthritis Guideline Puts Exercise Above Supplements
How the 2019 ACR/Arthritis Foundation osteoarthritis guideline ranks exercise and weight loss above glucosamine and fish oil, and why.
Evidence and research methods
Why the Headline and the Study So Often Disagree
Exaggeration in health headlines usually starts in the university press release, not the newsroom. Here is how to trace any claim back to the study.
Medicines and drug development
Why Removing a Peptide From the FDA's Safety-Risk List Is Not the Same as Approving It
Removing a peptide from the FDA's Category 2 safety-risk list in 2026 is not approval, not Category 1, and not permission to compound
Evidence and research methods
Why Placebo Response Is So Large in Depression Trials
Why placebo response runs high in antidepressant trials, and how a strong placebo arm compresses the measured drug-placebo gap.
Prevention, nutrition, and travel health
Why One-Time Aneurysm Screening Targets Older Men Who Ever Smoked
How the USPSTF anchored its grade B abdominal aortic aneurysm screening to older men who ever smoked, and why women and nonsmokers fall lower.
Infection, immunity, and cancer
Why One Positive Lyme Test Is Not a Diagnosis: Two-Tier Serology Explained
How two-tier Lyme serology works, why antibody tests miss early infection and stay positive after treatment, and why testing low-risk patients misleads.
Physician-scientist and medical humanities
Why One Diabetes Threshold Does Not Fit Every Population
Insulin sensitivity and insulin secretion vary across populations, so a single global cutoff can both miss and mislabel diabetes risk.
Skin, musculoskeletal, and eye health
Why Methotrexate Is Still the Anchor Drug in Rheumatoid Arthritis
A plain-language guide to the 2021 ACR rheumatoid arthritis guideline: how graded evidence keeps methotrexate first, sets a disease target, and limits steroids.
Digital health and AI
Why Interoperability Decides Whether Digital Health Works
What interoperability means in healthcare, why it is so hard, and why it often determines whether a digital health tool actually helps clinicians and patients.
Heart, lung, and acute care
Why How Your Blood Pressure Is Measured Changes the Diagnosis
How office technique, home readings, and 24-hour monitoring can each decide a hypertension diagnosis, and what the 2025 AHA/ACC guideline changed.
Women's, men's, and reproductive health
Why Hormone Therapy Is Not Recommended to Prevent Heart Disease or Dementia
The USPSTF gives hormone therapy a Grade D for preventing chronic disease. Here is why that verdict is separate from treating menopause symptoms.
Evidence and research methods
Why Guidelines Stopped Recommending Aspirin for Most Healthy Adults
How newer randomized trials reshaped aspirin advice for healthy adults, weighing bleeding against benefit and why established disease is different.
Skin, musculoskeletal, and eye health
Why Daily Baby Moisturizer Did Not Prevent Eczema in Large Trials
Large randomized trials (BEEP and PreventADALL) found daily infant moisturizer did not prevent eczema and may raise skin infection risk.
Brain, aging, and sleep health
Why CGRP Drugs Became First Line for Migraine Prevention
What the 2024 American Headache Society position statement changed about CGRP migraine prevention, and the evidence that moved these drugs to first line.
Evidence and research methods
Why Antidepressant Withdrawal Numbers Disagree So Much
Withdrawal-incidence estimates swing from about 15% to over 40%. Here is how study design, not biology, drives most of that gap.
Health policy, systems, and equity
Why a Cost-Effectiveness Threshold Is Really an Opportunity-Cost Question
A cost per QALY threshold measures health displaced elsewhere in a fixed budget, not a price for health. How NICE applies its range and why it is contested.
Skin, musculoskeletal, and eye health
Why a Biologic and a JAK Inhibitor Can Share the Same Eczema Grade
The 2024 AAD eczema guideline gives dupilumab, tralokinumab and oral JAK inhibitors one strong recommendation. That grade is not a safety ranking.
Diabetes and metabolic health
Why 'Diabetes Insipidus' Was Renamed Arginine Vasopressin Deficiency (AVP-D)
How a 2022 endocrine working group replaced 'diabetes insipidus' with etiology-based names, and what the patient safety evidence behind the change shows.
Evidence and research methods
Why '1 in 100' Beats '1 Percent': Communicating Risk Clearly
Natural frequencies like '1 in 100' and icon arrays are read more accurately than percentages, because they keep the denominator in plain sight.
Evidence and research methods
Who Gets to See the Raw Trial Data? IPD Sharing Explained
What a trial's data-sharing statement really promises, who can obtain individual participant data, and why reanalysis can confirm or overturn a result.
Skin, musculoskeletal, and eye health
Which Actinic Keratosis Treatment Works Best? Reading the Head to Head Trial
A New England Journal of Medicine trial compared four field therapies for actinic keratosis and one cream came out ahead at one year.
Medicines and drug development
When the Factory Is the Pharmacy: How CMC and GMP Decide If a Cell or Gene Therapy Reaches a Patient
For cell and gene therapies, manufacturing quality (CMC and GMP), not the biology, is usually the step that decides whether treatment arrives.
Medicines and drug development
When Nature Has Already Run the Experiment: Genetics and the Odds a Drug Target Works
Why a drug target linked to disease by human genetics is about twice as likely to reach approval, and how the strength of that evidence varies.
Skin, musculoskeletal, and eye health
When Is Mohs Surgery the Right Choice? How the Appropriate Use Criteria Were Built
How a 17-member panel rated 270 clinical scenarios to turn skin-cancer evidence into consistent decisions about when Mohs surgery is worth it.
Digital health and AI
When a Confident AI Makes a Good Clinician Worse
New experiments show a wrong but confident AI suggestion can drag a trained clinician's reasoning below no help at all. Here is what they measured.
Skin, musculoskeletal, and eye health
What the USPSTF I Statement on Skin Cancer Screening Actually Means
A USPSTF grade I on skin cancer screening means the evidence is insufficient to weigh benefits and harms, not that screening was shown to fail.
Heart, lung, and acute care
What the LoDoCo2 Trial Says About Low-Dose Colchicine for Residual Cardiovascular Risk
A plain-language appraisal of LoDoCo2, the trial testing daily 0.5 mg colchicine for residual cardiovascular risk in chronic coronary disease.
Skin, musculoskeletal, and eye health
What the Evidence Really Shows About Isotretinoin, Depression, and Bowel Disease
Large meta-analyses find no isotretinoin link to depression or bowel disease; teratogenicity, not mood, is the real reason iPLEDGE exists.
Physician-scientist and medical humanities
What Global Clinical Development Actually Involves
A plain-language tour of how a medicine moves through worldwide clinical programs, and why doing it well takes years.
Digital health and AI
What Continuous Glucose Monitoring Data Can and Cannot Tell You
CGM reliably improves glucose control for people on insulin. For most other claims the evidence is thinner. Here is how to read them.
Health policy, systems, and equity
What Changed in FDA's 2026 Clinical Decision Support Guidance
A plain explainer of FDA's January 2026 updates to its clinical decision support and general wellness guidance, and what now sits under enforcement discretion.
Skin, musculoskeletal, and eye health
What Can a Cosmeceutical Label Legally Say?
FDA law recognizes cosmetics and drugs, not cosmeceuticals. A single structure or function claim can push a skincare product across the drug line.
Medicines and drug development
What an Expiry Date Really Proves: Inside ICH Q1 Stability Testing
What the printed expiry date certifies, and how the consolidated draft ICH Q1 guideline defines the testing that stands behind it.
Skin, musculoskeletal, and eye health
What an Approved Aesthetic Trial Actually Proves
A plain-language guide to reading the evidence behind cosmetic procedures, using glabellar-line botulinum toxin as the worked example.
Imaging and radiology
What ALARA Really Means and How to Read a CT Radiation Dose
A plain-language guide to CTDIvol, dose-length product, and effective dose, and what ALARA, Image Gently, and Image Wisely actually ask of a scan.
Infection, immunity, and cancer
What a Positive Antibody Test Does and Does Not Tell You About Immunity
FDA and CDC say a positive antibody test records prior contact with a pathogen, not immunity. Here is how it differs from a validated correlate of protection.
Evidence and research methods
What a Meta-Analysis Can and Cannot Tell Us in Diabetes Research
How systematic reviews and meta-analyses synthesize evidence, why they rank high in the evidence hierarchy, and where their limits lie.
Digital health and AI
What a Hospital's AI Governance Program Is Supposed to Do
What the Joint Commission and CHAI responsible-AI guidance asks hospitals to do, and the questions that reveal whether a program is real or on paper
Medicines and drug development
Wearables in Clinical Trials: What Fit for Purpose Really Requires
How FDA verification and validation expectations decide whether a wearable trial endpoint is real evidence or just a marketing number.
Physician-scientist and medical humanities
Umbrella, Basket, and Platform Trials: What the FDA's Master-Protocol Guidance Actually Changes
A neutral explainer of the FDA's 2026 revised draft guidance on master protocols and the tradeoffs of shared controls and multiplicity.
Evidence and research methods
Two Ways to Count a Trial: Intention-to-Treat and Per-Protocol
Intention-to-treat preserves randomization and estimates a real-world effect. Per-protocol answers a narrower question and can let selection bias back in.
Mental and behavioral health
Therapy, Medication, or Both for Depression: Reading the Comparative Evidence
What effect sizes, number needed to treat, and network meta-analyses actually say about therapy, medication, and combined care for depression.
Mental and behavioral health
The Pharmacology of Coming Off an Antidepressant Slowly
Why equal antidepressant dose cuts have unequal effects, what receptor-occupancy math predicts, and where the tapering evidence is still thin.
Health policy, systems, and equity
The Netflix Model for Medicines: How Delinked Subscription Payment Works
How delinked subscription payment works for antibiotics, why the UK adopted it, and the market incentive it is built to correct.
Infection, immunity, and cancer
The Math Behind Herd Immunity and Why the Threshold Is Not One Number
Herd immunity has no single threshold. The 1 minus 1/R0 formula rises with transmissibility, and its assumptions rarely hold in the real world.
Diabetes and metabolic health
The Incretin System: How Gut Hormones Tell Your Body a Meal Has Arrived
How incretin hormones like GLP-1 signal after eating to shape insulin release, stomach emptying, and appetite, explained in plain language.
Diabetes and metabolic health
The Genetics of Type 2 Diabetes: What Your Genes Do and Do Not Predict
How type 2 diabetes genetics actually work, from polygenic risk and beta-cell biology to what a DNA report can and cannot tell you.
Medicines and drug development
The First AI-Designed Drug Reached Phase 2a: What the Trial Actually Showed
An evidence appraisal of rentosertib's phase 2a IPF trial, separating the AI discovery milestone from what 71 patients over 12 weeks can prove.
Imaging and radiology
The Evidence Behind Lung Cancer Screening: NLST, NELSON, and Number Needed to Screen
What the NLST and NELSON trials, number needed to screen, and overdiagnosis reveal about who actually benefits from low-dose CT lung screening.
Prevention, nutrition, and travel health
The Evidence Behind HPV Self-Collection for Cervical Cancer Screening
Why concordance and accuracy studies convinced guideline panels to list a patient-collected swab as an acceptable way to start HPV-based cervical screening.
Health policy, systems, and equity
The EU AI Act's Four Risk Tiers, and Why Clinical AI Usually Lands in the High-Risk Band
A plain explainer of the EU AI Act risk tiers, why most medical AI is high-risk, the core obligations that follow, and the phased timeline.
Health policy, systems, and equity
The EU AI Act Digital Omnibus: Why the High-Risk Deadlines Moved
The 2026 Digital Omnibus reset EU AI Act deadlines to December 2027 for Annex III systems and August 2028 for AI in regulated products.
Physician-scientist and medical humanities
The Declaration of Helsinki and What Its 2024 Revision Added
How the WMA Declaration of Helsinki governs human research and what its October 2024 revision changed for consent, biobanks, and emergencies.
Physician-scientist and medical humanities
The Belmont Report and the Three Principles Behind Every Ethics Review
The 1979 Belmont Report distilled human-research ethics into three principles that still shape how every ethics board judges a study.
Mental and behavioral health
The Antidepressant Boxed Warning for Young People, and What Followed
Why the FDA pooled 24 pediatric trials into a suicidality boxed warning, what the absolute risks actually were, and how researchers study the aftermath.
Health policy, systems, and equity
The Accelerated-Approval Bargain: Surrogate Endpoints, Confirmatory Trials, and Faster Withdrawal
How FDA accelerated approval trades a surrogate endpoint for a required confirmatory trial, and how the 2022 FDORA reforms tightened that bargain.
Women's, men's, and reproductive health
The 2025 Menopause Hormone-Therapy Label Reset: Which Warnings Went, Which Stayed, and Why
A neutral explainer of the FDA's November 2025 removal of the menopausal hormone therapy boxed warning, and what the label change does not mean.
Brain, aging, and sleep health
The 2024 McDonald Criteria: How Multiple Sclerosis Is Diagnosed Now
How the 2024 McDonald criteria diagnose MS earlier using the optic nerve, the central vein sign, and kappa free light chains, with new safeguards against error.
Medicines and drug development
The 100 Days Mission and What Makes a Vaccine Platform Truly Ready
A practical guide to appraising vaccine platform readiness against CEPI's 100 Days Mission dimensions instead of taking readiness claims on trust.
Heart, lung, and acute care
The 0.70 Cutoff in COPD Diagnosis: Fixed Ratio Versus Lower Limit of Normal
Why GOLD keeps a fixed FEV1/FVC below 0.70 for COPD, and where it overdiagnoses older adults and underdiagnoses younger ones versus LLN.
Skin, musculoskeletal, and eye health
Tendinopathy and the Case for Loading Over Rest
Why tendinopathy care shifted from rest toward heavy-slow-resistance and eccentric loading, and how strong that evidence really is.
Heart, lung, and acute care
STRONG-HF and the Four Pillars: What the Trial Really Tested About Heart-Failure Therapy
What the STRONG-HF trial tested about rapid up-titration of heart-failure drugs, why it stopped early, and how to read speed and sequencing claims.
Skin, musculoskeletal, and eye health
Stopping Denosumab: What the Rebound-Fracture Evidence Shows About Discontinuation
Why stopping denosumab without a follow-on drug lets bone turnover rebound and vertebral fractures cluster, and what FREEDOM data and guidelines advise.
Digital health and AI
Six Questions to Ask Before You Trust a Healthcare AI Tool
A six-question checklist for judging whether a clinical AI tool is safe to deploy: purpose, evidence, validation, transparency, monitoring, and accountability.
Women's, men's, and reproductive health
Should an MRI Come Before the Prostate Biopsy? Reading the PRECISION Trial
How the PRECISION randomized trial tested putting an MRI ahead of prostate biopsy, and what its findings do and do not settle.
Evidence and research methods
Relative Risk, Absolute Risk, and Number Needed to Treat: How to Read a Statin Trial
How to turn a statin trial's headline relative risk reduction into absolute benefit and number needed to treat, so one result stops sounding two ways.
Evidence and research methods
Reading Tumor Response on a Scan: What RECIST Can and Cannot Tell You
How RECIST 1.1 turns serial scans into response categories, why immunotherapy defies those rules, and how iRECIST handles pseudoprogression.
Infection, immunity, and cancer
Reading the Numbers on Approved Microbiome Medicines for Recurrent C. diff
Recurrent C. diff now has two FDA-approved microbiome products. Here is what Rebyota and Vowst do, and how to read their trial results honestly.
Imaging and radiology
Reading the MASAI Trial: What the First Randomized Test of AI in Mammography Shows
A plain-language guide to the MASAI trial, the first randomized test of AI in breast screening, and what its endpoints do and do not prove.
Skin, musculoskeletal, and eye health
Reading the Evidence Behind the First FDA-Authorized AI Skin Cancer Device
A plain-language guide to what FDA authorization of the first AI skin cancer device proves, and how to read its sensitivity, NPV, and specificity.
Skin, musculoskeletal, and eye health
Reading the 2024 Acne Guidelines: How Treatments Are Graded and Why Antibiotics Are Rationed
A plain-language guide to how the 2024 AAD acne guidelines grade benzoyl peroxide, retinoids and combinations, and why topical antibiotics are never used alone.
Kidney, digestive, and blood health
Reading FIB-4 Correctly: A Triage Score, Not a Fibrosis Stage
What FIB-4 can and cannot tell you about liver scarring, how it feeds the AASLD noninvasive pathway, and where the score misleads.
Women's, men's, and reproductive health
Reading a Dense-Breast Notification: What the DENSE Trial Can and Cannot Tell You
How to interpret a dense-breast notification and what the DENSE randomized trial found about adding a screening MRI, benefit and harm side by side.
Skin, musculoskeletal, and eye health
PRP for Tennis Elbow: Why the Answer Depends on the Clock and the Syringe
A cited walk through the randomized trials on platelet-rich plasma for tennis elbow, and why timing and preparation change the verdict.
Chronic disease in primary care
Preventive Care Across a Lifetime: Why a Long Relationship With a Generalist Pays Off
How the goals of prevention shift by life stage, and why continuity with a generalist who knows your whole story steadily improves the care you get.
Mental and behavioral health
Prescription Digital Therapeutics for Mental Health: What FDA Clearance Does and Does Not Mean
What FDA clearance of a prescription digital therapeutic like Rejoyn actually certifies, what its depression trial measured, and why cleared is not approved.
Evidence and research methods
Predictive Versus Prognostic Cancer Biomarkers Explained
How predictive and prognostic cancer biomarkers differ, why the interaction test matters, and what PD-L1 and TMB actually tell you.
Health policy, systems, and equity
Predicate Devices and Substantial Equivalence, Explained for Medical Software
How a device reaches market by matching a predicate, what substantial equivalence really proves, and why software strains the logic.
Evidence and research methods
Prebunking: The Science of Inoculating People Against Health Misinformation
What recent trials show about prebunking and inoculation theory for resisting health misinformation, and where the effects fade.
Kidney, digestive, and blood health
PPI Deprescribing and the Evidence on Long-Term Harms
Why proton pump inhibitors should be stopped when the indication ends, not because a study linked them to harm, and how to read that evidence.
Kidney, digestive, and blood health
Portal Hypertension in Cirrhosis: What Baveno VII Changed
Baveno VII rules clinically significant portal hypertension in or out from liver stiffness and platelet count, without a catheter pressure reading.
Diabetes and metabolic health
Polygenic Risk Scores for Type 2 Diabetes: What They Can and Cannot Do Today
A polygenic risk score for type 2 diabetes sorts groups by inherited risk but cannot predict any one person, and ancestry changes how accurate it is.
Physician-scientist and medical humanities
Polygenic Risk Scores for Coronary Artery Disease: How Much Do They Actually Add?
A plain-language look at what coronary polygenic risk scores measure, the modest accuracy they add, and why they transfer poorly across ancestries.
Skin, musculoskeletal, and eye health
Physical Activity as a Vital Sign: What Clinical Measurement Actually Means
In 2026 Medicare begins paying for a standardized physical activity assessment. Here is what treating movement as a routine clinical measure really means.
Diabetes and metabolic health
Pharmacogenomics Explained: How Your Genes Can Shape the Way a Medicine Works
How inherited gene differences change a drug's effect, with real promise for a few medicines and honest limits for most of them.
Medicines and drug development
Peptide Medicines on the Pharmacy Shelf: What "Approved" Actually Means
Insulin and GLP-1 medicines are peptides that cleared full FDA review. How approved peptide drugs differ from unapproved ones sold online.
Women's, men's, and reproductive health
PCOS as a Cardiometabolic Condition: What the 2023 International Guideline Recommends Testing
The 2023 PCOS guideline treats the syndrome as cardiometabolic, yet recommends the OGTT, HbA1c and lipids over routine fasting-insulin testing.
Health policy, systems, and equity
Paying for a Cure You Can Only Give Once: How Outcomes-Based and Annuity Agreements Work
How outcomes-based, annuity, and warranty agreements let payers cover one-time gene therapies despite uncertain long-term durability
Infection, immunity, and cancer
Passive Immunity: How Monoclonal Antibodies Protect Without Training the Immune System
How preformed antibodies like palivizumab and nirsevimab give immediate, temporary RSV protection, and how that differs from a vaccine.
Brain, aging, and sleep health
Painful Diabetic Neuropathy: How the AAN Graded the Evidence
Why the AAN found several drug classes work about equally for painful diabetic neuropathy, and how OPTION-DM confirmed it head to head.
Evidence and research methods
P-Hacking: The Hidden Choices That Manufacture Significance
How undisclosed analysis choices manufacture statistical significance, and why disclosure and preregistration are the fix.
Women's, men's, and reproductive health
Osteoporosis Drugs, Fracture Reduction, and the Drug-Holiday Question
Why bisphosphonates prevent far more hip fractures than they cause rare atypical femur fractures, and why a drug holiday is a reassessment rather than a rule.
Skin, musculoskeletal, and eye health
Osteoarthritis or Inflammatory Arthritis: How the Evidence Distinguishes Them
How guidelines and classification criteria separate osteoarthritis from inflammatory arthritis using stiffness, symmetry, and inflammatory markers
Medicines and drug development
Organ-on-Chip Systems: What It Takes to Trust One for a Real Decision
How an organ-on-chip earns regulatory trust: context of use, reference compounds, reproducibility, and measured predictive performance, not lifelike appearance.
Medicines and drug development
Orforglipron: What Does the Oral GLP-1 Evidence in ATTAIN-1 Actually Show?
A neutral appraisal of the ATTAIN-1 phase 3 trial of oral orforglipron, reading its weight and cardiometabolic results against injectable benchmarks.
Health policy, systems, and equity
One Set of Principles, Many Rulebooks: Harmonizing AI Medical Devices
How the 2025 IMDRF N88 document moves FDA, EU, and other regulators toward shared expectations for AI-enabled medical devices.
Medicines and drug development
One Peptide, Four Legal Lives: The Categories US Law Keeps Separate
FDA-approved, 503A/503B-compounded, research-only, and bulk-list peptides are four separate legal states, and one status never implies another.
Evidence and research methods
Number Needed to Treat: How Many People to Help One
Number needed to treat counts how many people must take a treatment for one of them to benefit, turning a trial result into a figure you can picture.
Evidence and research methods
Number Needed to Harm, and How to Read It Against Number Needed to Treat
Number needed to harm counts how many people are treated before one is harmed. Read it beside number needed to treat to weigh both sides.
Women's, men's, and reproductive health
Non-Hormonal Hot Flash Drugs: What the Trials Actually Showed
What the SKYLIGHT trials and FDA approval of fezolinetant reveal about a modest hot flash benefit set against a boxed liver warning.
Brain, aging, and sleep health
Night Shift Work and Cancer Risk: How IARC Graded the Evidence
Why IARC calls night shift work "probably carcinogenic," what Group 2A does and does not mean, and why the human cancer evidence is graded as limited.
Brain, aging, and sleep health
Nerve Conduction Studies and EMG: What They Actually Measure
A plain-language guide to what nerve conduction studies and EMG measure, why they favor specificity, and how sensitivity and their limits shape a diagnosis.
Physician-scientist and medical humanities
Narrative Medicine and Why Patient Stories Matter
What narrative medicine is, why a patient's story sharpens care, and how stories and evidence work together rather than against each other.
Brain, aging, and sleep health
NAD Boosters: Evidence Versus Marketing
NR and NMN reliably raise blood NAD+ in trials, but no controlled study proves they slow aging, and legal status says nothing about benefit.
Infection, immunity, and cancer
Multi-Cancer Early Detection Blood Tests and What the Evidence Shows
What multi-cancer early detection blood tests measure, why a randomized mortality trial is the real test, and the open overdiagnosis questions.
Imaging and radiology
MRI Safety: Why the Magnet Is Always On and What That Means for Implants
How the always-on MRI magnet, the ACR four-zone layout, and MR Conditional labeling combine into one practical implant-safety system.
Diabetes and metabolic health
Monogenic Diabetes and MODY: When a Single Gene Drives the Diagnosis
A plain explainer on monogenic diabetes and MODY, the rare single-gene forms that are often mistaken for type 1 or type 2.
Physician-scientist and medical humanities
MODY: The Single-Gene Diabetes That Often Wears the Wrong Label
Why MODY gets mistaken for type 1 or type 2 diabetes, the clues that should trigger genetic testing, and how the right gene changes treatment.
Digital health and AI
Model Cards and Nutrition Labels for Health AI, Explained
What a health AI model card is, and how a voluntary CHAI nutrition label differs from binding FDA device labeling.
Brain, aging, and sleep health
Mobile Stroke Units: Does Bringing the CT to the Patient Help
What the reperfusion and outcome evidence says about mobile stroke units, why the 2026 guideline endorses them, and the cost and access questions left open.
Prevention, nutrition, and travel health
Metabolic Syndrome: Reading a Cluster of Risk, Not a Diagnosis
What metabolic syndrome measures, why five risk factors cluster, and why the label is an early warning you can still act on rather than a verdict.
Women's, men's, and reproductive health
Menopause as a Metabolic Event: What the SWAN Cohort Shows About Insulin Resistance and Fat Redistribution
How the SWAN cohort reframes midlife metabolic change in women as a time-locked event tied to the final menstrual period, not ordinary aging.
Mental and behavioral health
Measurement-Based Care: What Repeated Symptom Scores Add to Treatment
What the trial evidence really shows about tracking PHQ-9 and GAD-7 scores in depression and anxiety care, and where that evidence is strong or thin.
Kidney, digestive, and blood health
MASLD and MASH: Why Fatty Liver Disease Was Renamed
Why liver societies replaced NAFLD and NASH with MASLD and MASH in 2023, what the MetALD category adds, and how to appraise a disease renaming.
Health policy, systems, and equity
Managed Entry Agreements: Paying for a Drug Before the Evidence Is In
How managed entry agreements let payers cover costly new drugs before the evidence is settled, and why outcomes-based deals are so hard to monitor.
Infection, immunity, and cancer
Lynch Syndrome and Why Tumors Are Screened Universally
Why every colorectal and endometrial tumor is tested for mismatch repair loss to catch inherited Lynch syndrome, and how the specific gene guides surveillance.
Women's, men's, and reproductive health
Low-Dose Aspirin for Preeclampsia: Reading ASPRE and the USPSTF Recommendation
How the ASPRE trial and the USPSTF grade B aspirin recommendation for preeclampsia differ on dose, screening, and absolute risk.
Mental and behavioral health
Loneliness and Health: How Strong Is the Mortality Evidence
What loneliness research actually shows about mortality, where the smoking comparison came from, and why the causal size stays uncertain.
Infection, immunity, and cancer
Latent vs Active TB: What a Positive Skin Test or IGRA Really Tells You
A positive TB skin test or IGRA proves immune memory, not live disease. Here is why the test cannot tell latent from active, and how risk is judged.
Skin, musculoskeletal, and eye health
Knee Arthroscopy for a Worn Meniscus: What the Sham Trials Revealed
What sham-controlled trials found when knee arthroscopy for a degenerative meniscus tear was tested against placebo surgery, and the lessons for evidence.
Kidney, digestive, and blood health
Kidney Stones: What the Prevention Evidence Actually Supports
Fluid has broad guideline backing but a weak grade; thiazides, citrate, and allopurinol help mainly in urine-defined subgroups.
Kidney, digestive, and blood health
JAK2 V617F: How One Mutation Became a Major Criterion for Polycythemia Vera
Why JAK2 V617F and exon 12 mutations carry such weight in the WHO criteria for polycythemia vera, and what a negative test still leaves open.
Diabetes and metabolic health
Is Type 2 Diabetes Inherited? What Family History Really Means
How type 2 diabetes runs in families, why it is not simple inheritance, and what a family history does and does not predict.
Skin, musculoskeletal, and eye health
Is Melanoma Overdiagnosed? What Rising Incidence and Flat Mortality Reveal
Rising melanoma diagnoses alongside a flat death rate suggest overdiagnosis, driven by more biopsies and thin, in situ lesions rather than more lethal disease.
Mental and behavioral health
Involuntary Psychiatric Care: How the Ethics and Evidence Are Weighed
How liberty and safety trade off in involuntary psychiatric care, what human-rights guidance now recommends, and why the outcome evidence stays thin.
Evidence and research methods
Intention to Treat: Why a Fair Trial Counts Everyone It Enrolled
What intention-to-treat analysis means, why it keeps randomized trial results honest, and how dropping participants can distort what a study appears to show.
Diabetes and metabolic health
Insulin Signaling Explained: What Happens After Insulin Reaches a Cell
How insulin works inside a cell, from the receptor to IRS proteins to the PI3K and AKT relay to GLUT4, and where insulin resistance breaks the chain.
Evidence and research methods
Insulin Sensitivity and Insulin Response: Why the Two Numbers Only Make Sense Together
Insulin sensitivity and insulin response are two different measurements, and diabetes risk lives in how they relate, not in either value alone.
Diabetes and metabolic health
Insulin Secretion: How the Beta Cell Measures Blood Sugar and Responds
How the pancreatic beta cell senses glucose and releases insulin, why failing secretion drives type 2 diabetes, and what that means for treatment.
Diabetes and metabolic health
Insulin Resistance vs Beta-Cell Failure: Two Roads to the Same Blood Sugar
A high glucose reading can come from tissues ignoring insulin or from a pancreas that cannot make enough, and the two need different care.
Digital health and AI
Insulin Pumps and Closed-Loop Systems: How Automation Steadies Control
A plain-language guide to how insulin pumps and closed-loop artificial pancreas systems work, and why automating small dosing decisions holds glucose steadier.
Infection, immunity, and cancer
Innate vs Adaptive Immunity: The Two Defense Systems and How They Divide Labor
Innate immunity reacts in hours with fixed receptors and no memory; adaptive immunity takes days but learns a specific pathogen and remembers it.
Diabetes and metabolic health
Inflammation and Diabetes: How Low-Grade Immune Activity in Fat Tissue Drives Insulin Resistance
How low-grade inflammation in fat tissue links to insulin resistance and type 2 diabetes, explained in plain, honest terms.
Medicines and drug development
Inclisiran and the ORION Trials: What Does an LDL Surrogate Endpoint Prove?
What ORION-10 and ORION-11 measured for a twice-yearly siRNA, and why an LDL surrogate endpoint is not the same as proof of fewer heart attacks.
Imaging and radiology
Incidentalomas, How Radiologists Decide What Is Worth Chasing
How probability, size thresholds, and ACR white papers decide which incidental imaging findings get worked up and which are safely left alone.
Medicines and drug development
Immunogenicity and Anti-Drug Antibodies: Why the Body Sometimes Fights a Biologic
How labs use a tiered assay strategy to detect anti-drug antibodies, and how to tell a clinically meaningful result from a lab curiosity.
Diabetes and metabolic health
ICH M13A and How the World Is Standardizing Generic Bioequivalence Testing
How ICH M13A harmonizes fasting and fed bioequivalence study design across the US, EU, and Japan, and why it matters for global generic access.
Kidney, digestive, and blood health
IBD Versus IBS: How the Two Are Told Apart
Why a stool protein called fecal calprotectin, the cutoff behind it, and a patient's baseline risk decide who can skip colonoscopy when separating IBD from IBS.
Prevention, nutrition, and travel health
Hypoglycemia Explained: What Low Blood Sugar Is and Why It Deserves Calm Respect
Hypoglycemia is when blood sugar drops too low. Learn the early signs, why it happens, and why a personal plan with your clinician matters.
Digital health and AI
Human in the Loop: Designing Clinical AI That Supports Judgment
Why clinical AI works best when a trained person keeps the authority to review, override, and own every decision before it reaches a patient.
Women's, men's, and reproductive health
HPV Self-Collection: How Its Accuracy Compares to Clinician Sampling
How the FDA clearance and the 2025 ACS guideline weigh the accuracy of a self-collected HPV sample against a clinician-collected one.
Infection, immunity, and cancer
How We Know HIV PrEP Works and Why Adherence Changes the Number
Why PrEP's roughly 99 percent figure depends on the drug being present in the body, and how trials from iPrEx to lenacapavir proved it.
Chronic disease in primary care
How VTE Prophylaxis Decisions Are Risk Stratified in the Hospital
How the Padua and IMPROVE scores weigh clot risk against bleeding risk to guide hospital VTE prophylaxis for medical inpatients.
Infection, immunity, and cancer
How Vaccine Safety Is Monitored and Why VAERS Numbers Are Misread
Why a raw VAERS report count cannot prove a vaccine caused harm, and how controlled systems like the Vaccine Safety Datalink actually measure risk.
Evidence and research methods
How to Tell Whether a Systematic Review and Meta-Analysis Is Trustworthy
A practical order for reading a systematic review: the question, the search, risk of bias, the forest plot, heterogeneity, and the studies that went missing.
Prevention, nutrition, and travel health
How to Talk About Uncertainty With Patients
Honest, practical ways to communicate medical uncertainty without undermining trust, for clinicians and the patients they serve.
Evidence and research methods
How to Spot Spin in a Study Abstract or Press Release
Spin is the gap between what a study found and how it is sold. Read the methods, the named outcome, and the absolute numbers first.
Evidence and research methods
How to Spot a Predatory Journal
Check a journal against DOAJ, COPE membership, and the Think. Check. Submit. list rather than trusting its site or a flattering invitation email.
Prevention, nutrition, and travel health
How to Read the Adult Immunization Schedule Without Getting Lost
A plain-language guide to the colors, the age and condition columns, and the shared-decision rows on the CDC adult vaccine schedule.
Kidney, digestive, and blood health
How to Read Liver Function Tests
A practical guide to ALT, AST, alkaline phosphatase, and bilirubin, and how the R ratio sorts an abnormal panel into hepatocellular or cholestatic.
Heart, lung, and acute care
How to Read ARISTOTLE: Apixaban Versus Warfarin in Atrial Fibrillation
A plain-language appraisal of the ARISTOTLE trial and the ordered testing plan that let a non-inferiority study report apixaban as superior to warfarin.
Skin, musculoskeletal, and eye health
How to Read an Ergogenic-Aid Claim: The Short Evidence-Backed List
How sports scientists grade ergogenic-aid claims, and why only a few substances like creatine and dietary nitrate have real support.
Kidney, digestive, and blood health
How to Read an Anemia Workup Without Jumping to Conclusions
Why ferritin, transferrin saturation, and MCV are read together, and how inflammation can hide real iron deficiency behind a normal-looking ferritin.
Brain, aging, and sleep health
How to Read an Alzheimer Drug Trial: CDR-SB and What Counts as Meaningful
A plain-language guide to the CDR-SB endpoint, lecanemab's 0.45-point result, and why "clinically meaningful" is still debated.
Diabetes and metabolic health
How to Read a Thyroid Panel Without Overinterpreting a Single Number
Read TSH and free T4 as a pair, tell overt from subclinical patterns, and catch the biotin, illness, and timing artifacts that fake abnormal results.
Chronic disease in primary care
How to Read a Study About Orthopedic Surgery Without Fooling Yourself
A physician's guide to judging orthopedic surgery research: feeling better versus being better, sham trials, and outcomes that matter to patients.
Evidence and research methods
How to Read a PRISMA Flow Diagram in a Systematic Review
A practical walkthrough of the PRISMA flow diagram, the numbers that make a systematic review auditable, and the patterns that should make you pause.
Medicines and drug development
How to Read a Peptide Health Claim Like a Scientist
A five-part reader's test for peptide marketing: the evidence ladder, regulatory status, wording tricks, the "research only" label, and who profits.
Evidence and research methods
How to Read a Kaplan-Meier Curve: What the Steps, the Spread, and the Censoring Marks Mean
A Kaplan-Meier curve shows the share still event-free over time. Here is how to read its steps, gaps, and censoring marks honestly.
Evidence and research methods
How to Read a Health Headline Without Getting Fooled
A four-part checklist for decoding a health headline: the study design, who was studied, absolute versus relative effect, and who paid.
Evidence and research methods
How to Read a Forest Plot Without the Jargon
A plain-language guide to reading the forest plot in a meta-analysis: the lines, the boxes, the diamond, and what they really show.
Evidence and research methods
How to Read a Conflict of Interest Disclosure
How to read an ICMJE conflict of interest disclosure, why sponsored studies tilt toward favorable results, and why naming a conflict does not cancel it.
Evidence and research methods
How to Read a Cochrane Plain-Language Summary
A part-by-part guide to Cochrane plain-language summaries: where to find the question, the certainty rating, the search date, and the honest bottom line.
Evidence and research methods
How to Read a Cardiology Guideline: Class of Recommendation and Level of Evidence
How to read ACC/AHA cardiology guidelines: what Class of Recommendation and Level of Evidence mean, and why the two labels are rated separately.
Evidence and research methods
How to Read a Cancer Survival Statistic
Five-year, relative, and net survival explained, plus why lead-time and length-time bias make survival a weak test of whether screening saves lives.
Digital health and AI
How to Judge Whether an AI That Writes Clinical Notes Is Any Good
How to evaluate ambient AI scribe tools by omission, fabrication, certainty drift, and note bloat, using randomized and scoping evidence, not time saved.
Imaging and radiology
How to Judge an FDA Cleared Radiology AI Tool
What a 510(k) clearance really certifies, how to read sensitivity, specificity and AUC, and the validation gaps to check before trusting radiology AI.
Prevention, nutrition, and travel health
How to Explain Diabetes Risk to a Patient Without Scaring Them
Give diabetes risk as a plain number out of 100, separate what a patient can change from what they cannot, and end on one decision.
Prevention, nutrition, and travel health
How to Evaluate a Wellness Claim: A Calm, Practical Framework
A practical framework for judging any wellness claim, separating real evidence from testimonials and marketing.
Prevention, nutrition, and travel health
How to Evaluate a Weight-Loss Program or Claim Fairly
An evidence-based way to judge weight-loss programs and claims, the marketing patterns to watch for, and how to choose without self-blame.
Digital health and AI
How to Evaluate a Symptom Checker
How to judge an AI symptom checker: what it is for, how it treats uncertainty, and whether it points you toward care when it matters.
Prevention, nutrition, and travel health
How to Evaluate a Supplement or Wellness Claim Without Getting Fooled
A reader's checklist for supplement and wellness claims: how they are regulated, what evidence counts, and the marketing red flags to watch.
Skin, musculoskeletal, and eye health
How to Appraise the Evidence Behind an Aesthetic Procedure
A practical framework for reading the evidence behind a cosmetic procedure: legal category, study design, outcome durability, and harms reporting.
Health policy, systems, and equity
How the WHO Essential Medicines List Is Actually Chosen
An independent WHO committee meets every two years and weighs effectiveness, safety, and comparative cost to choose essential medicines.
Health policy, systems, and equity
How the WHO Classifies Digital Health, and Why a Shared Vocabulary Matters
The WHO framework sorts digital health tools by whom they serve. Here is how it works and why a common language helps evaluate technology.
Evidence and research methods
How the USPSTF Built Its First Adult Anxiety Screening Recommendation
How the USPSTF reached its 2023 Grade B for anxiety screening, why it stopped short for adults 65 and older, and how to read a split verdict.
Evidence and research methods
How the USPSTF Built Its Adult Depression Screening Recommendation
A plain-language walk through the USPSTF Grade B for adult depression screening, the evidence links behind it, and why follow-up systems count.
Kidney, digestive, and blood health
How the Sickle Cell Guidelines Weigh Hydroxyurea and Transfusion
A close read of the ASH 2020 sickle cell guidelines and how their two labels, strength and certainty, sort screening, transfusion, and hydroxyurea advice.
Mental and behavioral health
How the PTSD Treatment Guideline Ranks the Therapies
How the 2023 VA/DoD PTSD guideline used GRADE to rank therapies, why several were downgraded, and what a strong recommendation actually requires.
Prevention, nutrition, and travel health
How the Preventive Services Task Force Stays Independent, and What It Deliberately Leaves Out
How the USPSTF uses volunteer experts, continuous conflict disclosure, and cost-blind grading to stay a trusted evidence authority in prevention.
Skin, musculoskeletal, and eye health
How the Osteoporosis Screening Recommendation Was Built
A plain-language look at how the 2025 USPSTF osteoporosis statement uses DXA, FRAX, and treatment trials to reach a B recommendation.
Infection, immunity, and cancer
How the Lung Cancer Screening Guideline Was Built
How USPSTF set the age and pack-year rules for low-dose CT lung screening by weighing lives saved against false positives and overdiagnosis.
Kidney, digestive, and blood health
How the GERD Diagnosis and Reflux Testing Actually Work
How the ACG 2022 guideline uses a PPI trial, endoscopy, and pH testing to confirm, or overturn, a GERD diagnosis.
Heart, lung, and acute care
How the Evidence Separates COPD From Asthma
Why no single test tells COPD from asthma, and how history, spirometry, and bronchodilator response combine to sort them out.
Infection, immunity, and cancer
How the Colorectal Screening Guideline Weighs Colonoscopy Against Stool Tests
Why the USPSTF lowered the colorectal screening start age to 45 and how it compares colonoscopy, FIT, and stool-DNA without naming one best test.
Diabetes and metabolic health
How the Body Keeps Blood Sugar Stable, Hour by Hour
How insulin, glucagon, the liver, and muscle hold blood sugar in a narrow range all day, and what type 2 diabetes disrupts in that loop.
Imaging and radiology
How the ACR Appropriateness Criteria Turn Evidence Into an Imaging Recommendation
How an ACR imaging appropriateness rating is built: a graded literature review plus a RAND/UCLA panel vote on a 1 to 9 scale, and how to read it.
Chronic disease in primary care
How Syncope Risk Scores Are Built and Validated
How the Canadian Syncope Risk Score was derived and validated, and why sensitivity and net benefit tell you more than any single cutoff.
Prevention, nutrition, and travel health
How Supplement Law Works: The DSHEA Premarket Gap
Why supplements reach the market without FDA premarket approval under DSHEA, and what the FDA disclaimer really signals.
Kidney, digestive, and blood health
How Stroke Risk Scores Guide Anticoagulation in Atrial Fibrillation
How the 2023 U.S. atrial fibrillation guideline shifted from a single CHA2DS2-VASc cutoff to an annual-risk threshold and several validated scores.
Health policy, systems, and equity
How Severity Weighting Changes What a Health System Will Pay
How severity modifiers and QALY shortfall (absolute vs proportional) reset the effective price a health system pays for a treatment
Heart, lung, and acute care
How Researchers Define a Moving Target Called Long COVID
Why the broad 2024 NASEM clinical definition and the narrower NIH RECOVER symptom score disagree about who has Long COVID, and what that means for research.
Digital health and AI
How Regulators Think About Generative-AI Mental-Health Chatbots
How FDA and its advisers weigh therapy-style AI chatbots, and why hallucination, sycophancy, and automation bias shape the oversight debate
Health policy, systems, and equity
How Regulators Grade Clinical Evidence, and Why the Bar Moves With Risk
Regulators weigh clinical evidence on quality, directness, and totality, then set a higher bar where the intended use and potential harm demand it.
Prevention, nutrition, and travel health
How Quitting Tobacco Became One of the Few Grade A Preventive Services
Why tobacco cessation earned a USPSTF Grade A while pharmacotherapy in pregnancy stayed an I statement, and how the grading system works.
Evidence and research methods
How Preregistration and Registered Reports Curb Bad Science
A reader's guide to preregistration and Registered Reports, and how the order of plan versus results helps you judge a study's claims.
Health policy, systems, and equity
How Post-Market Surveillance Works: Watching a Device After It Reaches Patients
A plain guide to how regulators and manufacturers keep monitoring a medical device after approval, from incident reports to periodic safety updates.
Chronic disease in primary care
How Pneumonia Severity Scores Help Decide Who Needs the Hospital
Pneumonia severity scores predict 30-day death risk, not whether home is safe. What PSI and CURB-65 measure, and how the 2019 ATS/IDSA guideline frames them.
Brain, aging, and sleep health
How Perfusion Imaging Extended the Stroke Treatment Window
How the DAWN and DEFUSE 3 trials used perfusion imaging to select late stroke patients for thrombectomy, and why the criteria are narrow.
Diabetes and metabolic health
How PCOS Is Actually Diagnosed, and Why AMH Was Added in 2023
How the 2023 international guideline diagnoses PCOS, when ultrasound or AMH is needed, and the age rules that guard against overdiagnosis.
Brain, aging, and sleep health
How Much Protein Do Older Adults Actually Need?
The 0.8 g/kg RDA versus expert proposals of 1.0 to 1.2 g/kg for older adults, and what the evidence does and does not settle.
Health policy, systems, and equity
How Much Evidence Proves a Drug Works? Two Trials, One Trial, or One Plus Confirmatory Evidence
How the FDA substantial-evidence standard works, from the two-trial default and FDAMA 115 to the 2026 one-trial-plus-confirmatory-evidence shift
Infection, immunity, and cancer
How MSI-High and Mismatch Repair Testing Guides Immunotherapy
Why MSI-High and mismatch repair deficiency predict immunotherapy response, and how they became the first marker used to approve a drug across any solid tumor.
Mental and behavioral health
How Mental Health Apps Are, and Are Not, Regulated
Most mental health apps are not FDA-reviewed. Here is why, what that means for evidence, and how to judge an app.
Imaging and radiology
How Lung-RADS Turns a Lung Nodule Into a Management Plan
How the Lung-RADS v2022 system turns a screen-detected lung nodule into a cancer probability and a next step, and what the 2022 update changed.
Heart, lung, and acute care
How LDL Targets Are Set in the 2026 Cholesterol Guideline
How the 2026 ACC/AHA dyslipidemia guideline turns trial data into risk-based LDL goals and a statin, ezetimibe, PCSK9 treatment cascade.
Infection, immunity, and cancer
How Investigators Read an Outbreak: Case Definitions, Attack Rates, and the Epidemic Curve
A plain-language guide to the three tools field epidemiologists use to read an outbreak, and the built-in blind spot in each.
Diabetes and metabolic health
How Insulin Therapy Works, and Why It Copies the Body's Own Rhythm
How insulin therapy replaces a missing hormone by imitating the body's natural pattern of background and mealtime release, and why it deserves careful handling.
Infection, immunity, and cancer
How Immune Checkpoint Inhibitors Work and Why Response Is Uneven
How PD-1, PD-L1, and CTLA-4 blockade release the immune system's brakes, and an evidence-based look at why only some tumors respond.
Heart, lung, and acute care
How Idiopathic Pulmonary Fibrosis Is Diagnosed and Slowed
How the 2022 ATS/ERS/JRS/ALAT guideline diagnoses IPF from the UIP pattern and multidisciplinary discussion, and how antifibrotics slow FVC decline.
Health policy, systems, and equity
How ICER Builds a Value Assessment, Beyond the Price
How ICER combines an evidence-rating matrix with cost-effectiveness modeling to judge a drug's value, and what the method can and cannot settle.
Health policy, systems, and equity
How Hospitals Get Paid a Fixed Price Per Case: DRGs and Activity-Based Funding
How diagnosis-related groups pay hospitals a fixed price per case, the incentives that creates, and why several countries are now rebalancing them.
Evidence and research methods
How GRADE Turns Evidence Into a Recommendation
How GRADE rates certainty of evidence and uses the Evidence-to-Decision framework to reach strong or conditional guideline recommendations.
Skin, musculoskeletal, and eye health
How Good Are the ABCDE Rule and Dermoscopy at Catching Melanoma?
What the evidence says about how well the ABCDE rule and dermoscopy catch melanoma, and why the user matters more than the tool.
Prevention, nutrition, and travel health
How GLP-1 Based Medicines Support Weight Management
How GLP-1 based medicines borrow the body's own appetite and satiety signals to support weight management, explained in plain terms.
Diabetes and metabolic health
How GLP-1 and GIP Work Together to Manage Blood Sugar and Appetite
GLP-1 and GIP are gut hormones released after eating that prime insulin, steady glucose, and shape appetite as a coordinated pair.
Diabetes and metabolic health
How GLP-1 and GIP Medicines Work, and Which Trial Number Measures Which Effect
How incretin drugs act on insulin, appetite, and gastric emptying, and how each action becomes an HbA1c, weight, or cardiovascular trial endpoint.
Chronic disease in primary care
How Frailty Is Measured: Phenotype Versus Deficit Index
The frailty phenotype flags a syndrome from five signs, while the deficit index scores accumulated health problems as a fraction. Here is how they differ.
Skin, musculoskeletal, and eye health
How Fast-Track Ultrasound Changed Giant Cell Arteritis Diagnosis
How the ultrasound halo sign performs in giant cell arteritis and why same-day scanning clinics are linked to less permanent sight loss.
Health policy, systems, and equity
How Evidence Becomes Health Policy, and Why Good Evidence Does Not Guarantee Good Policy
How evidence travels from studies to guidelines to health policy, and why strong evidence does not automatically make sound policy.
Chronic disease in primary care
How Early Warning Scores Like NEWS2 Flag Deterioration
How NEWS2 turns six vital signs into a deterioration score, what discrimination and thresholds mean, and how it compares with qSOFA.
Infection, immunity, and cancer
How Each Year's Flu Vaccine Strains Are Chosen and Why the Match Varies
How flu vaccine strains are picked months ahead, why antigenic drift causes mismatch, and how to read a low-effectiveness season.
Diabetes and metabolic health
How Drug Manufacturing Quality Is Controlled: GMP in Plain Terms
How Good Manufacturing Practice, batch records, and an independent quality unit turn an approved molecule into a dose you can trust.
Diabetes and metabolic health
How Doctors Screen for Cortisol Excess and Why One Abnormal Test Is Not a Diagnosis
How dexamethasone suppression, salivary, and urinary cortisol screening work, and why one abnormal test does not confirm Cushing syndrome.
Evidence and research methods
How Doctors Decide Which Test to Order for Chest Pain
Why stable chest pain leads to CT angiography, stress imaging, or no test at all, based on the estimated likelihood of coronary disease.
Evidence and research methods
How Depression Rating Scales Are Scored and Why the Cutoffs Are Debated
How depression rating scales like the Hamilton and MADRS are scored, what a clinically important difference means, and why their cutoffs are debated.
Chronic disease in primary care
How Delirium Is Detected With the Confusion Assessment Method
How the Confusion Assessment Method converts delirium criteria into a four-part bedside test, and how to read its sensitivity and specificity.
Evidence and research methods
How Decision Rules Rule Out Pulmonary Embolism Without a Scan
How Wells, PERC, age-adjusted D-dimer, and YEARS rule out pulmonary embolism safely, and the failure-rate evidence behind skipping the scan
Diabetes and metabolic health
How Combination Drug Therapies Are Developed
Why some medicines pair two drugs in one product, the extra proof that pairing demands, and how regulators judge whether each ingredient earns its place.
Evidence and research methods
How Clinical Guidelines Get Updated, and How to Read the Change
Guidelines change when a panel decides the advice no longer fits the evidence. How to read an update by its date, its trigger, and its dissent.
Health policy, systems, and equity
How Clinical Guidelines Are Written
How clinical guidelines are made: who sits on the panel, how evidence is graded, how conflicts are handled, and why the advice keeps changing.
Evidence and research methods
How Choosing Wisely Decides a Test Is Low Value
How specialty societies build Choosing Wisely lists, the three tests each item must pass, and why the evidence behind them varies enough to deserve appraisal.
Brain, aging, and sleep health
How CGRP Drives Migraine: From Mechanism to Medicine
How a single neuropeptide, CGRP, moved from a lab curiosity to a validated migraine drug target, and why two different medicine classes now confirm the biology.
Kidney, digestive, and blood health
How Celiac Disease Is Diagnosed Without Guesswork
Why tTG-IgA plus a total IgA comes first, why gluten must stay in the diet during testing, and when guidelines allow diagnosis without a biopsy.
Infection, immunity, and cancer
How CAR T Cell Therapy Works, and Why Its Risks Come Built In
How CAR T therapy reprograms a patient's own T cells against CD19 or BCMA, and why cytokine release syndrome and ICANS are mechanism-linked.
Infection, immunity, and cancer
How Cancer Staging Works and Why Stage Predicts Outcome
How the TNM system and AJCC prognostic stage groups turn tumor size, node spread, grade, and biomarkers into a survival estimate.
Heart, lung, and acute care
How Biomarkers Pick a Biologic for Severe Asthma
How blood eosinophils, FeNO, and IgE map type 2 airway inflammation and steer the choice among anti-IL-5, anti-IL-4/13, anti-IgE, and anti-TSLP biologics.
Evidence and research methods
How Basket Trials Support Tumor-Agnostic Drug Approvals
Why basket trials group cancers by shared mutation, how NTRK-fusion drugs earned tumor-agnostic approval, and what single-arm evidence cannot settle
Infection, immunity, and cancer
How Antibiotic Resistance Emerges and What Stewardship Actually Does
Why antibiotic resistance is a selection problem, how the CDC ranks the threats, and what controlled evidence says stewardship achieves.
Evidence and research methods
How and Why a Trial Chooses Its Primary Endpoint
Why a trial commits to one primary endpoint, the trade-offs between hard outcomes and surrogates, and what the choice reveals to a reader.
Digital health and AI
How AI Is Changing Drug Discovery, and Where the Hype Outruns the Evidence
AI speeds up the front of the drug pipeline, targets, molecules, and property prediction. Here is where those gains stop and why human trials still decide.
Evidence and research methods
How Adaptive and Platform Trial Designs Work, and What They Trade Off
A plain-language guide to adaptive randomization, arm-dropping, and platform trials, and the efficiency they buy against the discipline they demand.
Chronic disease in primary care
How Acute Kidney Injury Is Staged, and Why It Is Not the Same as CKD
How KDIGO stages acute kidney injury by creatinine and urine output, and why AKI and chronic kidney disease are graded apart.
Prevention, nutrition, and travel health
How ACIP Turns Vaccine Evidence Into a Recommendation
How ACIP uses GRADE and the Evidence to Recommendations framework to weigh benefits, harms, values, cost and equity before voting on a vaccine.
Health policy, systems, and equity
How Accountable Care Organizations Try to Pay for Health, Not Volume
A plain-language guide to how ACOs use spending benchmarks, shared savings, and downside risk, and why the benchmark math decides whether the model works.
Prevention, nutrition, and travel health
How a USPSTF Letter Grade Is Actually Decided
A, B, C, D, or I is not one score but two judgments crossed together: how sure the evidence is, and how much good the service does.
Medicines and drug development
How a Shortage List Made Compounded GLP-1 Drugs Legal, and Then Made Them Stop
Compounded semaglutide and tirzepatide were legal only while the FDA listed a shortage. When the lists closed in 2024 and 2025, the copies had to end.
Infection, immunity, and cancer
How a Screening Guideline Is Built: The Case of Mammography at 40
A plain-language look at how the USPSTF turned limited trials and six simulation models into its 2024 Grade B call for mammography every two years from age 40.
Health policy, systems, and equity
How a QALY Is Calculated and What It Cannot Capture
How a QALY combines a utility weight and time, and the documented limits of what this single cost-effectiveness number can capture
Skin, musculoskeletal, and eye health
How a Physical-Activity Guideline Is Built: Reading the 2026 ACSM Resistance-Training Update
How the 2026 ACSM resistance-training position stand grades exercise evidence and turns it into consistency-over-complexity conclusions.
Evidence and research methods
How a Perioperative Cardiac Risk Score Is Derived and Validated
How the Revised Cardiac Risk Index was built and tested, and what discrimination, calibration, and prediction versus causation actually mean.
Mental and behavioral health
How a Network Meta-Analysis Ranks 21 Antidepressants
How network meta-analysis links trials to compare 21 antidepressants on efficacy and acceptability, and why a single best drug never emerges.
Heart, lung, and acute care
How a High-Sensitivity Troponin 0/1-Hour Rule-Out Pathway Works
What a 0/1-hour high-sensitivity troponin pathway measures, why one hour is enough, and how to read the 99 percent sensitivity and NPV claims.
Prevention, nutrition, and travel health
How a Few Minutes of Alcohol Counseling Earned a B Grade, and Why It Stops at Adolescents
Why USPSTF gives adult alcohol screening plus brief counseling a B grade but rates the same service in teens an I statement.
Diabetes and metabolic health
How a Drug Gets Its Label and Its Approved Indication
What a drug label is, why the approved indication mirrors the trials that were run, and how on-label and off-label use differ in practice.
Diabetes and metabolic health
How a Companion Diagnostic Is Developed Alongside a Drug
A companion diagnostic is a test paired with a drug to find who benefits or is harmed. Here is how the pairing is built and validated.
Diabetes and metabolic health
How a Clinical Trial Protocol Is Designed, Section by Section
A section-by-section guide to what a clinical trial protocol contains and why fixing the rules in advance keeps the final answer honest.
Diabetes and metabolic health
How a Biotin Supplement Can Fake a Thyroid Disorder on a Blood Test
How high-dose biotin supplements distort streptavidin-based thyroid immunoassays, producing a lab picture that mimics Graves disease.
Heart, lung, and acute care
Home Oxygen for COPD: What the Trials Actually Show
Home oxygen extends COPD survival only in severe resting hypoxemia; the 2016 LOTT trial found no benefit for moderate desaturation.
Evidence and research methods
High, Moderate, Low, Very Low: How GRADE Rates the Certainty of Evidence
A plain-language guide to how GRADE rates evidence certainty across five domains, and why a strong recommendation and strong evidence are not the same thing.
Infection, immunity, and cancer
Hereditary Cancer Risk and What BRCA Testing Can Tell You
BRCA testing is the end of a path, not a general screen. How a risk tool, counseling, and a result each answer a different question.
Kidney, digestive, and blood health
Hepatitis C: How a Chronic Infection Became Curable
Why hepatitis C is now curable, what "cure" (SVR12) really measures, and the reasoning behind screening every adult aged 18 to 79.
Kidney, digestive, and blood health
Hepatitis B: How Serology Decides When Chronic Infection Is Treated
How HBeAg, HBsAg, ALT, and HBV DNA stage chronic hepatitis B, and why AASLD treats some phases with antivirals while monitoring others.
Physician-scientist and medical humanities
Henrietta Lacks, HeLa Cells, and the Consent Problem in Tissue Research
How the HeLa story and the 2013 NIH-Lacks family agreement turned informed consent from a one-time signature into ongoing governance of genomic data.
Kidney, digestive, and blood health
Helicobacter Pylori Test and Treat: How the Strategy and 2024 Guideline Work
How the 2024 ACG guideline reshaped H. pylori care, why bismuth quadruple therapy is now first line, and why a test of cure is required.
Heart, lung, and acute care
Heart Failure With Preserved Versus Reduced Ejection Fraction
What ejection fraction tells you about heart failure, why the preserved type is harder to diagnose, and why the two types have such different proven treatments.
Brain, aging, and sleep health
Healthspan Versus Lifespan, and Why the Difference Is the Point
Lifespan counts your years; healthspan counts the good ones. Why compressing illness into a short window matters more than any longevity product.
Brain, aging, and sleep health
Grip Strength as a Biomarker of Aging
Handgrip strength predicts death more strongly than systolic blood pressure, but it reads underlying health rather than driving it. Here is how to use it well.
Skin, musculoskeletal, and eye health
Gout Is a Crystal Disease: What the Urate Evidence Actually Shows
Why gout flares are an immune reaction to urate crystals, and why the ACR 2020 guideline treats serum urate to below 6 mg/dL rather than treating flares alone.
Digital health and AI
Good Machine Learning Practice: 10 Principles for Trustworthy Medical AI
A plain explainer of the FDA, Health Canada, and MHRA joint Good Machine Learning Practice principles for medical AI.
Diabetes and metabolic health
Glucose Toxicity Explained: How High Blood Sugar Harms the Cells That Lower It
High blood sugar can itself blunt insulin secretion and stress the beta cell, which is a central reason early glucose control pays off.
Diabetes and metabolic health
GLP-1 Receptor Agonists Beyond Weight Loss: Reading SELECT and FLOW
What the SELECT and FLOW trials actually tested about semaglutide's heart and kidney benefits, and how much is weight loss versus direct organ effects.
Physician-scientist and medical humanities
Gestational Diabetes, Explained Clearly
What gestational diabetes is, why pregnancy raises blood sugar, and what the diagnosis does and does not mean for the years ahead.
Imaging and radiology
Gadolinium Contrast Safety: What the ACR Group I, II, and III Labels Actually Tell You
A plain-language guide to how the ACR groups gadolinium contrast agents by nephrogenic systemic fibrosis cases, and why chemistry alone does not set the label.
Physician-scientist and medical humanities
From Bench to Bedside in Diabetes: Why So Few Discoveries Reach a Patient
How a diabetes discovery becomes a treatment, the stages of translational medicine, and why most promising findings never finish the journey.
Kidney, digestive, and blood health
Finerenone and Diabetic Kidney Disease: Reading FIDELIO and FIGARO
What FIDELIO-DKD, FIGARO-DKD, and the pooled FIDELITY analysis show about finerenone's kidney and heart benefits, and its hyperkalemia trade-off.
Women's, men's, and reproductive health
Finasteride and the High-Grade Prostate Cancer Scare: A Detection-Bias Lesson
How the Prostate Cancer Prevention Trial's alarming Gleason 7 signal turned out to be mostly a measurement artifact, with survival even over two decades.
Medicines and drug development
FDA Platform Technology Designation: Reusing Evidence Across a Drug Family
What FDA's Platform Technology Designation is, which technologies qualify, what it speeds up, and the approval limits it does not change.
Prevention, nutrition, and travel health
Fatty Liver and Type 2 Diabetes: A Two-Way Loop That Often Improves
Fatty liver and type 2 diabetes reinforce each other, usually without symptoms, yet the liver can genuinely recover with steady, unhurried care.
Digital health and AI
External Validation: Why a Model Must Prove Itself Outside Its Training Data
Why clinical AI usually loses accuracy at new sites and in later years, and how to tell a real external test from a reassuring-sounding one.
Evidence and research methods
External Control Arms: Reading a Trial That Never Randomized Its Comparator
A plain-language guide to single-arm and externally controlled trials, when regulators may accept them, and how comparability and timing can distort the result.
Health policy, systems, and equity
Expanded Access Versus Right to Try: Two Doors to an Unapproved Drug
How FDA Expanded Access and the federal Right to Try pathway differ in oversight, and why neither one proves a drug is safe, effective, or even obtainable
Mental and behavioral health
Exercise for Depression: How Strong Is the Evidence Really?
A large 2024 BMJ meta-analysis found exercise eased depression, but low confidence and the impossibility of blinding make it an adjunct, not a swap.
Skin, musculoskeletal, and eye health
Exercise for Depression and Anxiety: What Does the BJSM Umbrella Review Show?
How the 2023 BJSM umbrella review pooled 97 systematic reviews to estimate medium effects of physical activity on depression and anxiety.
Chronic disease in primary care
Evaluating the Evidence Behind Common Hand Surgery
How to read the evidence for hand and upper-limb procedures: fair comparisons, patient selection, timing, and weighing benefit against recovery.
Women's, men's, and reproductive health
Evaluating Low-T Claims: How Testosterone Deficiency Is Actually Diagnosed in the Evidence
What a defensible low testosterone diagnosis requires, and how to read a Low-T marketing claim against the published evidence.
Health policy, systems, and equity
EU MDR and Software as a Medical Device, in Plain Language
A plain guide to EU MDR, IVDR, and Software as a Medical Device: what counts as a device, how software is classified, and why the rules build clinical trust.
Brain, aging, and sleep health
Established Status Epilepticus: What the ESETT Trial Settled
The ESETT trial showed three second-line seizure drugs work about equally, and a null comparative result turns out to be genuinely useful.
Diabetes and metabolic health
Epigenetics and Diabetes: How Environment and Early Life Tune the Genes You Already Have
Epigenetics is how genes get turned up or down without changing the DNA letters, linking environment, early life, and diabetes risk.
Evidence and research methods
Efficacy Versus Effectiveness, and Why a Careful Reader Checks Which One Is Being Claimed
Efficacy is whether a treatment works under ideal conditions. Effectiveness is whether it works in everyday care. Check which one a claim means.
Physician-scientist and medical humanities
DPYD Testing Before 5-FU and Capecitabine: How Genotype-Guided Dosing Prevents Severe Toxicity
How a pretreatment DPYD gene test cuts the risk of severe 5-FU and capecitabine toxicity, what CPIC advises, and what a normal result cannot promise.
Heart, lung, and acute care
Does Treating Sleep Apnea Prevent Heart Attacks?
A randomized trial (SAVE) found CPAP did not cut heart attacks, despite strong observational links between sleep apnea and heart disease. Here is why.
Evidence and research methods
Does the Type of Talk Therapy Matter? Reading the Comparative Evidence
An evidence appraisal of the dodo bird debate and comparative meta-analyses on whether CBT outperforms other talk therapies
Skin, musculoskeletal, and eye health
Does Sunscreen Cause Vitamin D Deficiency? What the Evidence Says
Sunscreen blocks the UVB that makes vitamin D in a lab dish, yet population data show little clinically meaningful deficiency. Here is why.
Skin, musculoskeletal, and eye health
Does Sunscreen Actually Prevent Melanoma? Reading the One Randomized Trial
A close read of the Nambour trial, the only randomized study with a melanoma endpoint, and what its confidence intervals can and cannot support.
Prevention, nutrition, and travel health
Does Sugar Cause Diabetes? A Fair, Calm Answer
Sugar alone does not cause diabetes. Here is the honest relationship, the type 1 and type 2 difference, and why weight and energy balance matter more.
Heart, lung, and acute care
Does Pulmonary Rehabilitation Work for COPD? Reading the Trial Evidence
A physician reads the Cochrane trial evidence on pulmonary rehabilitation for COPD, and why the benefits are large enough to feel.
Evidence and research methods
Does Advance Care Planning Improve End-of-Life Care?
Randomized trials show advance care planning rarely makes end-of-life care match patients' wishes, a lesson in trusting countable proxies.
Heart, lung, and acute care
Does Adding a Second Drug to Your Statin Prevent More Heart Attacks? What the Trials Show
Whether adding ezetimibe or a PCSK9 inhibitor on top of a statin actually prevents cardiovascular events, and how big the benefit really is.
Prevention, nutrition, and travel health
Does a Weight-Loss Drug Prevent Heart Attacks? Reading the SELECT Trial
What the SELECT trial did and did not show about weekly semaglutide, heart attacks, and strokes in people with obesity and prior heart disease but no diabetes.
Digital health and AI
Does a Clinical Algorithm Work for Every Patient Group? Three Ways to Check
How to check a clinical algorithm serves every patient group, using representative data, subgroup testing, and post-launch monitoring.
Heart, lung, and acute care
Do Inhaled Steroids Help Every COPD Patient? What Blood Eosinophils Predict
Blood eosinophil counts help predict which COPD patients benefit from inhaled steroids, and where the GOLD treatment thresholds came from.
Imaging and radiology
Do CT Scans Cause Cancer? How to Weigh the Linear No Threshold Model
Why the 2025 projection of 103,000 CT-linked cancers is a model output, not a tumor count, and how to weigh low-dose radiation risk for a real scan.
Heart, lung, and acute care
Did Triple Inhaler Therapy Really Lower COPD Deaths?
Reading the ETHOS and IMPACT mortality signal honestly, and why the comparator, not the third drug, drives the result.
Prevention, nutrition, and travel health
Diabetes and Vaccines: A Practical Guide to Staying Ahead of Infection
Why vaccines carry a little extra weight when you live with diabetes, and how to fold them into routine care. Educational.
Physician-scientist and medical humanities
Diabetes and the Heart: Why Modern Care Is Increasingly Organ Protection
Modern type 2 diabetes care aims at the heart and kidneys themselves, not at the glucose number alone. Here is why the goal changed.
Prevention, nutrition, and travel health
Diabetes and Sleep Apnea: A Two-Way Link Worth Asking About
Sleep apnea and high blood sugar feed each other, the link often goes unnoticed, and your sleep is a fair thing to raise at a checkup.
Prevention, nutrition, and travel health
Diabetes and Planning a Pregnancy: Why the Months Before Matter
With type 1 or type 2 diabetes, blood glucose in the months before conception helps shape early development. Why preconception planning matters.
Prevention, nutrition, and travel health
Diabetes and Nerve Health: Early Signs and Why Steady Blood Sugar Protects Your Nerves
How diabetes affects nerves, the early signs to notice in the feet, and why steady blood sugar plus simple checks help protect feeling and function.
Prevention, nutrition, and travel health
Diabetes and Mental Health: The Emotional Weight Few People Talk About
Why diabetes carries a real mental and emotional load, what diabetes distress is, and why caring for your feelings is part of good care.
Prevention, nutrition, and travel health
Diabetes and Kidney Health: Why Early Checks Catch What Symptoms Miss
How diabetes affects the kidneys, why early changes cause no symptoms, and why two simple tests catch them while there is still room to act.
Prevention, nutrition, and travel health
Diabetes and Exercise: Why Movement Helps Your Blood Sugar
How regular movement lowers blood sugar and improves health in diabetes, and why even small, steady activity counts.
Prevention, nutrition, and travel health
Diabetes and Dental Health: Why the Mouth and Blood Sugar Affect Each Other
Diabetes and gum health influence each other in both directions, which is why dental care belongs inside a diabetes plan rather than beside it.
Imaging and radiology
Dense Breasts and Supplemental Screening: What the National Notification Rule Does and Does Not Prove
The MQSA final rule standardizes breast density notification. Here is what that notice proves about supplemental screening and what it does not.
Digital health and AI
Decision support in the diabetes visit: what actually helps
How clinical decision support works inside a real diabetes visit, what the trial evidence shows, and how to tell a useful tool from a demo.
Diabetes and metabolic health
Decentralized Clinical Trials: What the FDA's 2024 Final Guidance Allows and Guards Against
A plain-language guide to the FDA's 2024 final guidance on trials with decentralized elements, what it permits and the safeguards it keeps in place.
Digital health and AI
Data Quality for Clinical AI: The Model Is Only as Good as What It Learned From
Clinical AI rises or falls on its data. What trustworthy clinical data looks like, and why the flaws stay invisible until the tool reaches real patients.
Health policy, systems, and equity
DALY Versus QALY: Two Ways to Measure Health Loss
DALYs and QALYs both fold length and quality of life into one number, but they run on opposite scales and answer different questions. How to tell them apart.
Kidney, digestive, and blood health
Cystatin C Versus Creatinine: Why Two eGFR Estimates Can Disagree
Why creatinine and cystatin C eGFR values differ, what KDIGO 2024 advises, and how to read the mortality signal when they diverge.
Physician-scientist and medical humanities
CYP2C19 and Clopidogrel: What the FDA Warning and the CPIC Guideline Actually Establish
How CYP2C19 genotype blunts clopidogrel, what the FDA boxed warning and the 2022 CPIC guideline say, and where the outcome evidence is strong or thin.
Skin, musculoskeletal, and eye health
Creatine Monohydrate: What Does the ISSN Position Stand Actually Conclude?
A close reading of the 2017 ISSN position stand on creatine: strong evidence for performance and safety, weaker signals for clinical and neuroprotective use.
Health policy, systems, and equity
Coverage With Evidence Development: Paying for a Treatment While the Proof Is Still Coming In
A plain-language guide to how payers fund promising treatments under uncertainty while requiring real-world data, and why the exit is the hard part.
Skin, musculoskeletal, and eye health
Cosmetic, Drug, or Both? The Claim That Decides How a Product Is Regulated
In US law a product is a cosmetic or a drug based on what it claims to do, and that claim sets the evidence it must carry.
Imaging and radiology
Contrast-Induced Versus Contrast-Associated Kidney Injury: A Lesson in Confounding
Why controlled studies split real dye nephrotoxicity from coincidental kidney injury, and where the true risk still lives.
Women's, men's, and reproductive health
Contraception Risk in Two Numbers: Relative Versus Absolute
A headline can say a contraceptive "triples" clot risk while the true change is a handful of extra cases per 10,000 users. Here is how to read both numbers.
Evidence and research methods
Confounding and Causation: Why a Real Association Can Still Lie to You
Association is not causation. A confounder is a third factor tied to both cause and effect, and study design exists to rule it out.
Evidence and research methods
Composite Endpoints: When Studies Combine Outcomes
What a composite endpoint is, why trials use them, and how to read one without being misled by an impressive combined number.
Prevention, nutrition, and travel health
Common Myths About Type 2 Diabetes, Gently Corrected
The most common myths about type 2 diabetes, sorted from truth, so sugar, body size, willpower, and insulin stop carrying unfair blame.
Diabetes and metabolic health
Combination T4 Plus T3 Therapy for Hypothyroidism and What the Trials Actually Show
Why levothyroxine stays first line for hypothyroidism, what T4 plus T3 and desiccated thyroid trials show, and where real uncertainty remains.
Brain, aging, and sleep health
Closing a PFO After Unexplained Stroke: What the Trials Support
How RESPECT, CLOSE, REDUCE, and the RoPE score frame who benefits from PFO closure after an unexplained stroke under age 60.
Health policy, systems, and equity
Clinical Evaluation Versus Clinical Investigation, and Why Medical Software Needs Both
A clinical evaluation appraises existing evidence for a device. A clinical investigation runs a new study. Here is how the two differ and connect.
Health policy, systems, and equity
CE Marking Versus FDA Clearance: Two Routes a Medical Device Takes to Market
A neutral guide to how the EU CE marking route and the US FDA pathways differ, and what each label really signifies about a device.
Skin, musculoskeletal, and eye health
Carbon Monoxide Rebreathing: Diagnostic Tool or Doping Method?
How WADA's 2026 List draws method M1.4, banning carbon monoxide used to build blood while leaving diagnostic rebreathing that measures hemoglobin mass allowed.
Medicines and drug development
CAR-T's Boxed Warning for T-Cell Cancers: What the Evidence Does and Does Not Show
A plain-language read of the FDA's 2024 class-wide boxed warning for secondary T-cell cancers after CAR-T therapy, and the limits of the data behind it.
Infection, immunity, and cancer
Cancer Screening: Weighing Earlier Detection Against Overdiagnosis
Why cancer screening trades earlier detection for overdiagnosis, and how mortality trials, not survival figures, reveal which programs truly help.
Physician-scientist and medical humanities
Can Empathy Be Measured? What the Jefferson Scale Actually Captures
What the Jefferson Scale of Empathy really measures, why psychometricians trust it, and where the outcome evidence stops short.
Digital health and AI
Calibration vs Accuracy in Plain Terms, and Why Calibration Is the One That Keeps You Safe
Accuracy tells you how often a model is right. Calibration tells you whether its probabilities are true. Acting on a number needs calibration.
Diabetes and metabolic health
Calcium Channels and the Beta Cell: How a Tiny Gate Controls Insulin
How voltage-gated calcium channels trigger insulin release, and why variation in genes such as CACNA1E is linked to type 2 diabetes risk.
Skin, musculoskeletal, and eye health
Caffeine as an Ergogenic Aid: How to Read the ISSN Position Stand
A reader's guide to the 2021 ISSN caffeine position stand: which claims are load-bearing, which are hedged, and why averages predict little per person.
Infection, immunity, and cancer
C. diff Testing: Why a Positive PCR Does Not Always Mean Infection
A positive C. difficile PCR can signal carriage rather than disease; smart test selection plus toxin confirmation curbs overdiagnosis.
Prevention, nutrition, and travel health
Brown Fat and Metabolism: The Tissue That Burns Energy to Make Heat
What brown fat is, how it makes heat with UCP1, and what the evidence honestly shows about its role in metabolism.
Skin, musculoskeletal, and eye health
Botulinum Toxin for Frown Lines: Reading the Evidence Behind the Marketing
What placebo-controlled trials actually establish about botulinum toxin A for frown lines, and how a "responder rate" and an eyelid-droop figure should be read.
Chronic disease in primary care
Bone Health and Osteoporosis: How Bones Weaken Without Warning, and What Can Be Done
A plain-language guide to bone health and osteoporosis, why bone loss goes unnoticed, and how it is screened for and managed before a fracture.
Brain, aging, and sleep health
Blood Tests for Alzheimer: What p-tau217 Can and Cannot Do
A plain-language look at the first FDA-cleared Alzheimer's blood test and the 2025 guideline, including who it is for and where it falls short.
Diabetes and metabolic health
Biosimilar Interchangeability: Why Switching Studies May No Longer Be Required
The FDA has proposed dropping routine switching studies for interchangeable biosimilars, relying instead on analytical and pharmacokinetic evidence.
Health policy, systems, and equity
Biomarker Qualification Explained: Why a Measurement Has to Earn a Defined Use
Qualification means a biomarker is formally accepted for one defined use, not for everything. Why the bar is high, and how it protects patients.
Diabetes and metabolic health
Biologics vs. Pills: Why Protein Medicines Are Grown, Not Synthesized
Biologics are large proteins grown in living cells and usually injected; pills are small molecules built by chemistry. One difference drives the rest.
Brain, aging, and sleep health
Biological-Age and Epigenetic-Clock Tests: What They Actually Measure
What epigenetic clocks measure, how they are validated, and why a single biological-age result is not a personal lifespan verdict.
Diabetes and metabolic health
Bioequivalence for Narrow Therapeutic Index Drugs: How Tight Is Tight Enough
Why generics of narrow therapeutic index drugs face a tighter, reference-scaled bioequivalence limit while highly variable drugs get a controlled wider one.
Medicines and drug development
Beyond Animal Testing: What the FDA's New-Approach-Methodologies Roadmap Changes
How the FDA NAMs Roadmap begins replacing animal testing in preclinical safety, why it starts with monoclonal antibodies, and what Year 1 delivered.
Diabetes and metabolic health
Beta-Cell Mass vs Beta-Cell Function: Two Ways the Insulin Supply Falls Short
Beta-cell mass is how many insulin-making cells you have; function is how much each one secretes. In type 2 diabetes both decline, and they decline differently.
Women's, men's, and reproductive health
Benign Prostate Enlargement: Sorting Symptom Relief From Disease Modification
What trials of alpha-blockers, 5-alpha-reductase inhibitors, and combination therapy actually show about easing urinary symptoms versus slowing the disease.
Brain, aging, and sleep health
Bell Palsy: What the Steroid and Antiviral Evidence Shows
Why corticosteroids earn a strong recommendation for Bell palsy while antivirals do not, and how to read the guideline behind both verdicts.
Evidence and research methods
Basket, Umbrella, and Platform Trials: What Master Protocols Actually Do
How basket, umbrella, and platform trials differ, and how master protocols lead to tissue-agnostic FDA approvals.
Chronic disease in primary care
Balanced Crystalloids or Saline? Reading the Big Fluid Trials Honestly
What SMART, SALT-ED, BaSICS, and PLUS actually found about balanced fluids versus saline, and how composite outcomes shape the word "positive.
Infection, immunity, and cancer
Bacteria in the Urine Without Symptoms: Why the Answer Is Usually to Do Nothing
A positive urine culture without symptoms is asymptomatic bacteriuria, not a UTI. Guidelines say leave it alone, apart from two exceptions.
Brain, aging, and sleep health
Asymptomatic Carotid Narrowing: What CREST-2 Tells Us
What CREST-2 means for symptom-free carotid narrowing, and why the trial's low event rates matter more than which procedure "won.
Brain, aging, and sleep health
Aspirin Plus Clopidogrel After Minor Stroke: Reading POINT and CHANCE
How pooled POINT and CHANCE data set the 21-day window for aspirin plus clopidogrel after minor stroke, and why bleeding risk drew the line
Brain, aging, and sleep health
ARIA: What Amyloid Antibody Brain Imaging Changes Mean
What ARIA edema and hemorrhage mean with lecanemab and donanemab, and how titration, APOE4 testing, and MRI monitoring lower the risk.
Kidney, digestive, and blood health
Anticoagulation Basics: How the Evidence Picks the Drug
How guideline panels weigh DOACs against warfarin, when bridging heparin still helps, and why drug interactions keep warfarin in play for some patients.
Medicines and drug development
Antibody-Drug Conjugates: Following the Molecule From Bloodstream to Tumor Cell
How an ADC's antibody, linker, and payload each work, and why the mechanism alone does not tell you how much a given agent has proven.
Diabetes and metabolic health
An Adrenal Nodule Found by Accident: How the Evidence Guides the Next Step
How guidelines use CT density and a dexamethasone test to triage an incidental adrenal nodule and define mild autonomous cortisol secretion.
Diabetes and metabolic health
Amylin, the Second Hormone Your Beta Cells Release With Insulin
Amylin is co-secreted with insulin, slows how fast glucose reaches the blood after meals, and signals fullness. Here is what this hormone does.
Chronic disease in primary care
AI in Radiology: What It Can and Cannot Do Today, Honestly
AI in radiology helps with flagging, triage, and measurement, but it does not read scans alone, and the radiologist stays central.
Kidney, digestive, and blood health
Age-Adjusted D-Dimer: The Sticky-Note Rule That Cut Needless PE Scans
Why multiplying a patient's age by 10 to set the D-dimer threshold safely rules out pulmonary embolism in older adults, and where the rule stops.
Women's, men's, and reproductive health
After a High PSA, a Second Blood Test as Gatekeeper: Reading GOTEBORG-2 and the 4Kscore
What the GOTEBORG-2 screening trial found when a 4Kscore blood test was placed between an elevated PSA and the MRI and biopsy that usually follow.
Mental and behavioral health
Adult ADHD and the Overdiagnosis Debate, Explained by the Evidence
What overdiagnosis really means, why adult ADHD prevalence estimates range so widely, and how shifting criteria and context drive the disagreement.
Diabetes and metabolic health
Adrenergic Receptors and Insulin Secretion: How a Stress Signal Tells the Beta Cell to Pause
How adrenaline signaling tells the insulin-producing beta cell when to hold back, and why one receptor setting can nudge a person toward type 2 diabetes.
Women's, men's, and reproductive health
A Preventive Checklist for Men, Organized by What Actually Triggers Each Test
The short list of preventive screenings for men with strong guideline backing, sorted by the age, habit, or risk score that should prompt each one.
Diabetes and metabolic health
A Borderline TSH in an Older Adult Is Often Just Normal Aging
Why a single fixed TSH cutoff overdiagnoses subclinical hypothyroidism in older adults, and how age-specific reference ranges change who gets labeled.
Digital health and AI
Your health records and privacy: a calm primer
What happens to your health data, the basic rights you have over it, and a sensible, non-anxious way to think about health privacy.
Prevention, nutrition, and travel health
Which health screenings do you actually need
How evidence-based screening works, why more is not always better, and how to tell a worthwhile screening test from one that may do more harm than good.
Heart, lung, and acute care
When to call emergency services without hesitating
The situations where calling for emergency help is clearly the right move, and why hesitation is the common, avoidable mistake that costs the most.
Evidence and research methods
When the headline and the study disagree
A practical way to check a health news story against the research behind it, so you can tell solid reporting from overstatement.
Heart, lung, and acute care
When chest pain is an emergency, and when to call for help
How to think about chest pain, the features that mean call for help now, and why you should not wait or drive yourself to the hospital.
Digital health and AI
What good diabetes technology looks like
A plain, brand-neutral guide to the main diabetes technologies, what they do, and how to judge them by evidence and fit rather than marketing.
Evidence and research methods
What a nationwide registry study can and cannot tell us
Why large national health registries are a research powerhouse, what makes their findings strong, and where their limits lie.
Prevention, nutrition, and travel health
What a good medical conversation looks like
Shared decision making explained: what it is, why it improves care, and how patients and clinicians can do it well together.
Skin, musculoskeletal, and eye health
Understanding ACL injuries
What the ACL does, how it gets injured, the general choices between surgical and non-surgical paths, and why prevention programs work.
Health policy, systems, and equity
Trust in medicine, one visit at a time
How trust between patients and clinicians is actually built, why it matters for health, and the everyday behaviors that earn it.
Skin, musculoskeletal, and eye health
Treating a soft-tissue injury: from RICE to newer thinking
How first-aid advice for sprains and strains has evolved beyond RICE, what the changes mean in practice, and what the evidence does and does not settle.
Evidence and research methods
Statins and cancer outcomes: a lesson in reading the evidence
A careful look at what observational studies on statins and cancer can and cannot tell us, and why this topic is a good lesson in reading evidence well.
Heart, lung, and acute care
Sepsis: the emergency many people have never heard of
What sepsis is, the warning signs to know, and why recognizing it early and seeking emergency care quickly can be lifesaving.
Heart, lung, and acute care
Recognizing a stroke: why every minute matters
The FAST warning signs of a stroke, the other symptoms to know, and why calling for emergency help immediately can save a life and a future.
Prevention, nutrition, and travel health
Prevention across a lifetime: a decade-by-decade guide
How preventive care shifts as you age, from your twenties to your later years, and why the focus changes at each stage of life.
Skin, musculoskeletal, and eye health
Preventing running injuries: load, not luck
Why most running injuries come from training load rather than bad luck, and the practical habits that lower the risk without taking the joy out of running.
Skin, musculoskeletal, and eye health
Osteoporosis and bone health: prevention that works
How bones change through life, who should be screened for osteoporosis, and the practical steps that protect bone strength and prevent fractures.
Skin, musculoskeletal, and eye health
Osteoarthritis in plain language
What osteoarthritis is, why the old wear-and-tear story is incomplete, and the things that genuinely help, starting with movement.
Physician-scientist and medical humanities
Mentoring the next generation of clinicians
What good mentorship in medicine looks like, why it matters for both mentor and learner, and how to make it more than an accident.
Skin, musculoskeletal, and eye health
Low back pain: what actually helps
Why most low back pain improves, why staying active beats rest, when imaging is not needed, and the warning signs that do require prompt care.
Prevention, nutrition, and travel health
Lifestyle change that lasts
What the evidence says about making health habits stick, why small sustainable steps beat dramatic overhauls, and how to be kind to yourself in the process.
Health policy, systems, and equity
Language and culture at the bedside
Why being cared for in a language you fully understand improves safety and outcomes, and how professional interpreters and cultural awareness help.
Skin, musculoskeletal, and eye health
Joint pain: what is normal and when to seek care
How to think about joint pain, the warning signs that need prompt assessment, and when an ache is simply part of an active life.
Physician-scientist and medical humanities
How good clinicians stay current
Practical habits for keeping up with medical evidence without drowning in it, and why staying current is a skill rather than a burden.
Heart, lung, and acute care
Heat and cold emergencies: recognition and response
How to tell heat exhaustion from heat stroke and hypothermia from frostbite, what to do for each, and the red flags that mean call emergency services now.
Heart, lung, and acute care
Heart attack warning signs, including the easy-to-miss ones
The classic and the easily missed signs of a heart attack, why symptoms can differ between people, and why calling for help fast matters.
Physician-scientist and medical humanities
From registry to bedside: why population research helps patients
How research across whole populations connects to the care of one individual, and why a population view makes everyday medicine better.
Heart, lung, and acute care
Fever in adults: when it is just a fever and when it is not
Most fevers in adults are not emergencies. Learn the red flags, like confusion, a stiff neck, or trouble breathing, that mean you should seek care fast.
Skin, musculoskeletal, and eye health
Exercise as medicine: what the evidence supports
Why physical activity is among the most strongly supported things you can do for your health, what the guidelines say, and why some is always better than none.
Heart, lung, and acute care
ER, urgent care, or primary care: choosing the right one
A practical guide to where to go for what, the emergency red flags that always mean the ER, and how to choose calmly when it is not clear.
Evidence and research methods
Correlation, causation, and confounding, with real examples
Why two things moving together does not mean one causes the other, what confounding is, and how to think clearly about observational findings.
Heart, lung, and acute care
Controlling severe bleeding before help arrives
Practical first aid for serious bleeding: firm direct pressure, when a tourniquet helps, and why to call emergency services right away.
Skin, musculoskeletal, and eye health
Concussion: recognition, recovery, and return
What a concussion is, how to recognize it, why a gradual return matters, and the warning signs that mean urgent medical care.
Skin, musculoskeletal, and eye health
Common sports injuries: a clear overview
The common sports and activity injuries explained in plain terms, the difference between sudden and overuse injuries, and when to seek care.
Heart, lung, and acute care
Common myths about emergencies and first aid
Gentle, evidence-based corrections to widespread first-aid myths, from nosebleeds and burns to CPR and stroke, with what current guidelines actually advise.
Evidence and research methods
Cohort, case-control, trial: a field guide to study types
A friendly guide to the main kinds of medical studies, what each is good for, and why some sit higher than others when judging cause.
Heart, lung, and acute care
Choking and CPR: awareness that can save a life
What to do when someone is choking, the basics of Hands-Only CPR, and why a hands-on certified course is the thing that truly prepares you.
Skin, musculoskeletal, and eye health
Ankle sprains: recovery and getting back to activity
How ankle sprains happen, how they are graded, what recovery looks like, and the signs that mean a fracture should be ruled out.
Heart, lung, and acute care
Anaphylaxis and severe allergic reactions
How to recognize a severe allergic reaction, why epinephrine is the first and most important treatment, and why to call for emergency help every time.
Digital health and AI
AI in medicine: separating progress from hype
Where the evidence for artificial intelligence in healthcare is genuinely strong, where it is still thin, and how to read claims about it honestly.
Skin, musculoskeletal, and eye health
AI in eye screening: promise and limits, read honestly
What automated, AI-based diabetic retinopathy screening can do, where it genuinely helps, and the limits worth understanding.
Skin, musculoskeletal, and eye health
Acute versus overuse injuries, and why it matters
The difference between sudden and gradual injuries, why it changes how each is treated and prevented, and what load management really means.
Health policy, systems, and equity
Access is a clinical issue, not just a policy one
How distance, cost, and time shape health, why access belongs in the exam room, and what a practical, blame-free view looks like.
Evidence and research methods
Absolute versus relative risk: the difference that changes everything
Why a claim that a treatment cuts risk by 50 percent can mean a lot or almost nothing, and how to tell which, in plain terms.
Skin, musculoskeletal, and eye health
Wound Care for Minor Cuts and Scrapes: A Simple Guide
Wound care for minor cuts and scrapes made simple: how to clean a wound, dress it, spot infection, and know when to see a doctor.
Children and adolescent health
Why type 1 diabetes prompts a look for celiac disease
Why children with type 1 diabetes are checked for celiac disease, how the two autoimmune conditions overlap, and what screening involves.
Chronic disease in primary care
Why seeing the same clinician matters
What continuity of care means, the evidence linking it to better outcomes, and why an ongoing relationship is especially valuable in chronic disease.
Chronic disease in primary care
Why biological sex matters in type 1 diabetes
How biological sex relates to the age of onset, genetics, and immune profile of type 1 diabetes, and why that nuance supports more individual care.
Mental and behavioral health
When to Seek Help for a Mental Health Concern
Not sure when to seek help for a mental health concern? Learn the signs worth attention, the red flags that need urgent care, first steps, and 988.
Children and adolescent health
When a child's weight is a medical question, not a moral one
How clinicians and parents can talk about a child's weight in a way that helps rather than harms, focusing on health and respect over shame.
Skin, musculoskeletal, and eye health
What retinal imaging can show about the whole body
How modern retinal imaging works, what OCT and OCT angiography reveal, and why the eye offers a rare window onto the body's small blood vessels.
Physician-scientist and medical humanities
What a PhD adds to a clinician: a practical look
What research training contributes to question framing, evidence appraisal, and honest decisions under uncertainty in health care.
Skin, musculoskeletal, and eye health
Vision changes you should never ignore
The eye symptoms that deserve urgent attention, why timing matters, and how to tell a red flag from an everyday change.
Brain, aging, and sleep health
Vaccines That Matter More With Age: An Adult Guide
Which vaccines matter more with age? A calm guide to shingles, pneumococcal, enhanced flu, and RSV shots for older adults, and how to read the adult schedule.
Women's, men's, and reproductive health
Urinary tract infection: prevention and treatment guide
How urinary tract infection prevention and treatment actually work: when a UTI needs antibiotics, when it does not, how to avoid repeats, and the red flags.
Mental and behavioral health
Types of Therapy Explained: CBT, DBT, ACT, IPT
A plain-language guide to the main types of therapy (CBT, DBT, ACT, IPT), what each one treats, and how to find the right fit for your concern.
Chronic disease in primary care
Type 1 and type 2 diabetes: what the difference actually means for care
A plain-language guide to how type 1 and type 2 diabetes differ, and why getting the distinction right changes treatment, monitoring, and screening.
Prevention, nutrition, and travel health
Traveling With a Chronic Condition: How to Prepare
Traveling with a chronic condition? A doctor-informed guide to the pre-travel visit, packing medications safely, time-zone dosing, and a contingency plan.
Women's, men's, and reproductive health
The well-woman visit: a guide by age and life stage
A well-woman visit is a yearly preventive checkup for women. See what it includes and how the priorities shift by age, from screening to contraception.
Skin, musculoskeletal, and eye health
The diabetic eye exam: why it is core diabetes care
A diabetic eye exam catches retinopathy before any symptoms appear and shows how diabetes affects your whole vascular system. Here is what to know and when.
Prevention, nutrition, and travel health
The Adult Vaccine Schedule: Which Shots You Need and When
The adult vaccine schedule explained plainly: which vaccines most adults need yearly, which turn on with age, and how a clinician finds and closes gaps.
Skin, musculoskeletal, and eye health
Sun Protection That Works: What the Evidence Shows
Sun protection that works layers clothing, shade, timing, and sunscreen. See what the trials show, how much sunscreen to use, and which SPF to pick.
Brain, aging, and sleep health
Staying strong: exercise and protein for older adults
Exercise and protein for older adults rebuild muscle, cut fall risk, and protect independence. Here are the evidence-based numbers behind the guidelines.
Skin, musculoskeletal, and eye health
Skin Signs of Internal Disease: When to Take Notice
Skin signs of internal disease can appear early, sometimes before diabetes is diagnosed. Learn which skin changes to notice and when to see a clinician.
Skin, musculoskeletal, and eye health
Skin Cancer Signs and Skin Checks: What to Look For
Skin cancer signs and skin checks made simple: the ABCDEs of melanoma, a step-by-step self-exam, who is higher risk, and when to see a clinician.
Health policy, systems, and equity
Rural and border medicine: four lessons for better care
Rural and border medicine teaches four lessons for stronger primary care: continuity, resourcefulness, trust, and language. See what the evidence shows.
Women's, men's, and reproductive health
PSA Prostate Cancer Screening: Benefits, Harms, and Your Choice
Should you get a PSA prostate cancer screening? For men 55 to 69 it is a shared decision. Here are the modest benefits, the real harms, and how to weigh them.
Prevention, nutrition, and travel health
Protein, carbs, and fat: what actually matters
Protein, carbs, and fat each do real work. Quality and your overall eating pattern matter far more than chasing a perfect macronutrient ratio.
Prevention, nutrition, and travel health
Preventing Traveler's Diarrhea: Food, Water, and a Kit
A doctor's practical guide to preventing traveler's diarrhea: safe food and water habits, a simple travel health kit, treatment steps, and warning signs.
Chronic disease in primary care
Prediabetes is a fork in the road, not a verdict
What prediabetes means, why it is common and often silent, and the changes with the best evidence for keeping it from becoming type 2 diabetes.
Women's, men's, and reproductive health
Preconception Health: A Simple Checklist Before Pregnancy
Preconception health, explained simply: start folic acid early, steady any chronic conditions, review medications and vaccines, and prepare at your own pace.
Brain, aging, and sleep health
Polypharmacy in older adults: when more medicines is a problem
When does polypharmacy in older adults become a problem? A plain guide to the risks of too many medicines, the Beers Criteria, and safe deprescribing.
Children and adolescent health
Parental diabetes and a child's future health
What it means for a child when a parent has diabetes, how to read the association without alarm, and the supportive steps that help most.
Women's, men's, and reproductive health
Osteoporosis Screening for Women: When to Get a Bone Density Test
Osteoporosis screening for women, explained: who needs a bone density test, at what age, and what genuinely protects bone through and after menopause.
Brain, aging, and sleep health
Normal Aging vs Concerning Memory Changes: How to Tell
Normal aging vs concerning memory changes: how to tell everyday forgetfulness from dementia warning signs, what mimics dementia, and when to see a doctor.
Skin, musculoskeletal, and eye health
Moles vs Melanoma: How to Tell the Difference
The difference between a mole and melanoma comes down to change over time and the spot that stands apart. Learn the ABCDE rule and when to see a clinician.
Mental and behavioral health
Mental Health Screening Tools: PHQ-9 and GAD-7 Explained
How mental health screening tools like the PHQ-9 and GAD-7 work, what your score really means, and why a positive screen starts a conversation, not a label.
Women's, men's, and reproductive health
Menopause and Perimenopause Symptoms and Treatment
An evidence-based guide to menopause and perimenopause symptoms and treatment: how long hot flashes last, when hormone therapy fits, and nonhormonal options.
Women's, men's, and reproductive health
Men's Mental Health: Why the Gap Exists and How to Close It
Men's mental health is a recognition and access problem, not a character flaw. Why men avoid care, the signs of depression to watch for, and where to start.
Women's, men's, and reproductive health
Men's health checkups: what primary care covers
A plain guide to men's health checkups: the evidence-based screenings and shared decisions primary care actually covers, matched to age and risk.
Women's, men's, and reproductive health
Low Testosterone: What the Evidence Supports and What It Does Not
Low testosterone is diagnosed by symptoms plus repeated low morning tests, not marketing. Here is what testosterone therapy for men can and cannot do.
Prevention, nutrition, and travel health
Jet lag remedies: what actually helps on long-haul trips
The jet lag remedies that actually work: light timing, low-dose melatonin, and simple habits that help your body clock reset faster after long-haul flights.
Women's, men's, and reproductive health
Iron deficiency and heavy periods: when to check ferritin
Iron deficiency and heavy periods often go together. Learn how to tell if a period is heavy, when to check ferritin, and how treatment works.
Mental and behavioral health
How to Support a Loved One's Mental Health
How to support a loved one's mental health: what to say, warning signs to watch for, how to ask about safety and 988, and how to protect your own wellbeing.
Prevention, nutrition, and travel health
How to Read a Nutrition Label Without the Hype
How to read a nutrition label the way a physician does: start at the panel, check the serving size, and use %DV to spot highs and lows.
Evidence and research methods
How to read a medical study without a statistics degree
How to read a medical study without a statistics degree. A calm, six-step checklist for absolute risk, confidence intervals, p-values, and confounding.
Prevention, nutrition, and travel health
How to prevent insect-borne illness: an evidence-based guide
How to prevent insect-borne illness with layered, evidence-based steps: EPA-registered repellents, permethrin on clothing, fast tick checks, and travel prep.
Prevention, nutrition, and travel health
How to Prepare for Travel Health: A Pre-Trip Guide
How to prepare for travel health: a simple pre-trip plan covering the doctor visit, vaccines, malaria and diarrhea prevention, a kit, and chronic conditions.
Women's, men's, and reproductive health
Heart Health for Men: the 5 Numbers That Matter
Heart health for men comes down to five numbers: blood pressure, LDL, blood sugar, weight, and tobacco. See the targets and habits to raise with your clinician.
Brain, aging, and sleep health
Healthy Aging: What Actually Helps You Stay Well
Healthy aging is less about genetics than a few daily habits. See what the evidence says about movement, strength, sleep, connection, and prevention.
Chronic disease in primary care
HbA1c, explained for patients
What HbA1c measures, what the numbers mean, why targets are individual, and the situations where the test can read high or low.
Children and adolescent health
Growth, puberty, and metabolism: a primer for parents
What normal growth and puberty look like, how much variation is normal, and the few signs that are worth checking with a clinician.
Chronic disease in primary care
Family history of diabetes: what it does and does not tell you
How a family history of diabetes shifts risk for type 1 and type 2, why it is a prompt rather than a prediction, and what to do with it.
Brain, aging, and sleep health
Falls Prevention for Older Adults: What Actually Works
Falls prevention for older adults works best with balance and strength exercise, a medication review, up-to-date vision, and home safety. Here is the evidence.
Prevention, nutrition, and travel health
Evidence-based eating patterns: what the research supports
Which evidence-based eating patterns does the research support? A clear guide to the Mediterranean diet, DASH, their shared core, and simple swaps to start.
Women's, men's, and reproductive health
Erectile Dysfunction as a Health Signal: What It Means
Erectile dysfunction as a health signal can point to vascular, metabolic, or hormonal problems, sometimes years early. Here is why it is worth raising.
Skin, musculoskeletal, and eye health
Eczema and Dry Skin Care: A Practical Guide That Works
A clinician's guide to eczema and dry skin care: how to pick a moisturizer, calm flares, spot triggers, and know when to see a doctor.
Chronic disease in primary care
Early signs of type 1 diabetes in children
The early signs of type 1 diabetes in children, why catching them early prevents a dangerous emergency, and why it is never caused by diet.
Prevention, nutrition, and travel health
Dietary fiber for metabolic and gut health, explained
Dietary fiber for metabolic and gut health: most adults get only half the target. What fiber does for blood sugar and cholesterol, plus easy food swaps.
Skin, musculoskeletal, and eye health
Diabetic retinopathy in plain language
What diabetic retinopathy is, the stages it moves through, why it often has no early symptoms, and what can be done about it.
Chronic disease in primary care
Diabetes and the rest of the body: a clear overview
How diabetes can affect the eyes, kidneys, nerves, heart, and feet over time, and how steady, coordinated care lowers those risks.
Mental and behavioral health
Depression and Anxiety in Primary Care: What to Expect
How primary care handles depression and anxiety: what screening involves, how the PHQ-9 and GAD-7 work, treatment options, and how to get help (including 988).
Women's, men's, and reproductive health
Contraception in Primary Care: Methods and How to Choose
Contraception in primary care, explained simply: the five method groups, how effectiveness works (typical vs perfect use), and how to choose a fit.
Skin, musculoskeletal, and eye health
Common rashes and when to worry vs. when to wait
Common rashes and when to worry: a calm home framework for telling which rashes need same-day care and which can safely be watched, with clear red flags.
Women's, men's, and reproductive health
Colorectal Cancer Screening: When to Start and Which Test
Colorectal cancer screening now starts at 45 for average-risk adults. Compare colonoscopy vs FIT and stool DNA tests, and pick the one you will finish.
Digital health and AI
Clinical decision support: what it is and what works
What clinical decision support is, what the evidence shows, where alert fatigue bites, and why these tools support rather than replace a clinician's judgment.
Mental and behavioral health
Chronic Stress and Burnout: What the Evidence Actually Shows
Chronic stress and burnout are not the same thing. Here is what the research shows, where it stops short of proof, and practical first steps that hold up.
Children and adolescent health
Childhood obesity and metabolic risk: a generalist's guide
Childhood obesity and metabolic risk, explained plainly: what the link means, how clinicians screen, and why guidelines favor family-centered, blame-free care.
Women's, men's, and reproductive health
Cervical Cancer Screening: Pap vs HPV Test and Intervals
How current cervical cancer screening works, including preferred primary high-risk HPV testing, Pap and co-testing intervals, and qualified self-collection.
Prevention, nutrition, and travel health
Cardiometabolic prevention: what the evidence supports
An evidence-ranked guide to cardiometabolic prevention: what truly lowers heart and metabolic risk, from blood pressure and statins to diabetes prevention.
Prevention, nutrition, and travel health
Altitude, heat, and cold travel safety in the extremes
A prevention-first guide to altitude, heat, and cold travel safety: how to acclimatize, spot altitude sickness and heat stroke, and prevent cold injury.
Mental and behavioral health
Alcohol and Health Risks: What 'Moderate' Really Means
A calm, evidence-based look at alcohol and health risks: what a standard drink is, whether "moderate" is safe, and how primary care can help you cut back.
Brain, aging, and sleep health
Age-Related Hearing and Vision Changes: What Actually Helps
Age-related hearing and vision changes touch falls, driving, mood, and memory. Here is what the evidence shows and the practical steps that help.
Brain, aging, and sleep health
Advance Care Planning: How to Start Early (and Why)
Advance care planning explained in plain language: what it is, how a healthcare proxy and living will differ, and how to start the conversation with family.
Children and adolescent health
Adolescent screening: the checks that matter
What primary care screens for during the teenage years, why those checks matter, and how confidentiality fits in.
Prevention, nutrition, and travel health
Added sugar and ultra-processed foods: what the evidence shows
What the evidence really shows about added sugar and ultra-processed foods: the WHO sugar limit, the key studies, and the swaps worth making first.
Skin, musculoskeletal, and eye health
Acne treatment: what helps, what to skip
What helps acne, backed by evidence: the topical and oral treatments that work, what to skip, diet myths, and when to see a clinician.
No entries match that search.